Patent Grant
11426155
Embodiments of the present invention relate in general to valve replacement. More specifically, embodiments of the present invention relate to prosthetic valves for replacement of an atrioventricular valve.
Dilation of the annulus of the mitral valve prevents the valve leaflets from fully coapting when the valve is closed. Regurgitation of blood from the ventricle into the atrium results in increased total stroke volume and decreased cardiac output, and ultimate weakening of the ventricle secondary to a volume overload and a pressure overload of the atrium. Dilation of the annulus is sometimes treated by implanting a prosthetic mitral valve at a patient's native mitral valve.
For some applications of the present invention, one or more guide members (e.g., wires, sutures, or strings) is configured to be anchored to respective commissures of a native atrioventricular valve of a patient, and each guide member facilitates the advancement therealong of respective commissural anchors. The commissural anchors are shaped so as to define a plurality of barbs or prongs which are expandable to restrict proximal movement of the anchors following their deployment. The guide members facilitate advancement of a collapsible prosthetic valve support (e.g., a skirt) which serves as a base for and receives a collapsible prosthetic mitral valve which is subsequently coupled to the support. The support comprises a proximal annular element, or ring, and a distal cylindrical element. The cylindrical element is configured to push aside and press against the native leaflets of the native valve, and the proximal annular element is shaped so as to define one or more holes for sliding the valve support along the one or more guide members. The proximal annular element is configured to be positioned along the annulus of the native valve.
The collapsible prosthetic valve is configured for implantation in and/or at least partial replacement (e.g., full replacement) of the native atrioventricular valve of the patient, such as a native mitral valve or a native tricuspid valve. The valve support and the prosthetic valve are configured to assume collapsed states for minimally-invasive delivery to the diseased native valve, such as by percutaneous or transluminal delivery using one or more catheters. For some applications, the valve support and the prosthetic valve are implanted during an open-heart procedure.
The prosthetic valve support is shaped so as to define a downstream skirt. The downstream skirt is configured to be placed at native valve, such that the downstream skirt passes through the orifice of the native valve and extends toward, and, typically partially into, a ventricle. The downstream skirt typically additionally pushes aside and presses against the native leaflets of the native valve, which are left in place during and after implantation of the prosthetic valve support and/or the prosthetic valve.
The proximal annular element has upper and lower surfaces. For some applications of the present invention, one or more, e.g., a plurality of, tissue anchors are coupled to the lower surface and facilitate anchoring of the proximal annular element to the annulus of the native valve. For some applications, the one or more anchors comprise at least first and second commissural anchors that are configured to be implanted at or in the vicinity of the commissures of the native valve.
The cylindrical element of the valve support has first and second ends and a cylindrical body disposed between the first and second ends. The first end of the cylindrical element is coupled to the annular element while the second end defines a free end of the cylindrical element. For some applications of the present invention, the cylindrical element of the valve support is invertible such that (1) during a first period, the second end and the cylindrical body of the cylindrical element are disposed above the annular element (e.g., in the atrium of the heart), and (2) during a second period, the second end and the cylindrical body of the cylindrical element are disposed below the annular element (e.g., in the ventricle of the heart).
For some applications, techniques are applied to facilitate sealing of the interface between the valve support and the native valve, and/or the interface between the prosthetic valve and the native valve. For example, a sealing balloon may be placed on a valve-facing, lower side of the annular element of the valve support, the sealing balloon being configured to be inflated such that the balloon seals the interface between the valve support and the native valve. Alternatively or additionally, commissural helices are wrapped around chordae tendineae of the patient in order to facilitate sealing of the valve commissures around the valve support and/or around the valve. Further alternatively or additionally, the valve commissures are grasped by grasping elements that act in order to facilitate sealing of the commissures around the valve support and/or around the valve. For some applications, one or more of the aforementioned sealing elements facilitates anchoring of the prosthetic valve to the native valve in addition to facilitating sealing.
For some applications, the prosthetic valve comprises an expandable frame (e.g., a wire frame), and a sealing material (such as latex) is disposed on the outer surface of the frame so as to form webbing between at least some of the struts of the wire frame, and to provide sealing between the wire frame and the native valve.
For some applications, an invertible prosthetic valve support is used to support a prosthetic valve. Typically, a sealing element is disposed circumferentially around a surface of the invertible prosthetic valve support that is initially an inner surface of the invertible prosthetic valve support. The invertible prosthetic valve support is anchored to the native valve, and is subsequently inverted. Subsequent to the inversion of the invertible prosthetic valve support, the sealing element is disposed on the outer surface of the invertible prosthetic valve support and acts to seal the interface between the outer surface and the native valve.
There is therefore provided, in accordance with some applications of the present invention, apparatus, including:
a prosthetic valve support configured to be placed at an annulus of a native atrioventricular valve of a patient, the prosthetic valve support defining an annular element that defines an inner cross-sectional area thereof;
an expandable prosthetic valve configured to be placed into a ventricle of the patient, the prosthetic valve including:
the expandable frame of the prosthetic valve being configured such that when the frame is in a non-constrained state thereof, a cross-sectional area of the frame, along at least a given portion of a length of the frame, is greater than the cross-sectional area defined by the annular element of the prosthetic valve support,
the prosthetic valve thereby being couplable to the prosthetic valve support at any location along the portion, responsively to radial forces acted upon the valve support by the expandable frame, by the expandable frame being expanded when the location along the portion is aligned with the annular element of the prosthetic valve support.
For some applications, the valve support is collapsible for transcatheter delivery.
For some applications, the native atrioventricular valve includes a mitral valve, and the prosthetic valve includes three prosthetic leaflets.
For some applications, the annular element of the valve support is asymmetrically shaped.
For some applications, the annular element is shaped to define a hole, and a center of the hole is disposed asymmetrically with respect to an outer perimeter of the annular element.
For some applications, the frame includes proximally-facing protrusions at a distal end thereof, the protrusions being configured to prevent proximal migration of the valve into an atrium.
For some applications, the protrusions are disposed at an angle from the frame of more than 40 degrees.
For some applications, the protrusions are disposed at an angle from the frame of less than 80 degrees.
For some applications, a length of each of the protrusions is less than 5 mm.
For some applications, the frame includes a single proximally-facing protrusion corresponding to each native valve leaflet of the valve, each of the protrusions having a width of less than 1 mm.
For some applications, the protrusions are disposed in a sinusoidal configuration such that the protrusions conform with a saddle shape of the patient's native annulus.
For some applications, the protrusions are configured to prevent the native leaflets from interfering with a left ventricular outflow tract of the patient.
For some applications, the frame includes first and second sets of one or more protrusions, each set of protrusions configured to ensnare a respective native leaflet of the native valve of the patient, the first set of protrusions being disposed within a first circumferential arc with respect to a longitudinal axis of the prosthetic valve, on a first side of a distal end of the frame, the second set of protrusions being disposed within a second circumferential arc with respect to the longitudinal axis of the prosthetic valve, on a second side of the distal end of the frame, the first and second sets being disposed so as to provide first and second gaps therebetween at the distal end of the frame, at least one of the gaps having a circumferential arc of at least 20 degrees, the apparatus further including one or more valve guide members configured to be delivered to one or more commissures of the native valve, and to guide the valve such that the first and second circumferential arcs are aligned with respective leaflets of the native valve and such that the first and second gaps are aligned with respective commissures of the native valve.
For some applications, the at least one of the gaps has a circumferential arc of at least 60 degrees.
For some applications, the first circumferential arc defines an angle of between 25 degrees and 90 degrees about the longitudinal axis of the prosthetic valve.
For some applications, the second circumferential arc defines an angle of between 25 degrees and 90 degrees about the longitudinal axis of the prosthetic valve.
For some applications, the first circumferential arc defines an angle of between 45 degrees and 75 degrees about the longitudinal axis of the prosthetic valve.
For some applications, the second circumferential arc defines an angle of between 45 degrees and 75 degrees about the longitudinal axis of the prosthetic valve.
For some applications, the expandable frame of the prosthetic valve is configured such that when the frame is in a non-constrained state thereof the frame has a maximum diameter of less than 25 mm.
For some applications, the expandable frame of the prosthetic valve is configured such that when the frame is in a non-constrained state thereof the frame has a maximum diameter of more than 15 mm.
For some applications, the expandable frame of the prosthetic valve is configured such that when the frame is in a non-constrained state thereof the frame has a maximum diameter of less than 20 mm.
For some applications, the expandable frame of the prosthetic valve is configured such that when the frame is in a non-constrained state thereof, a cross-sectional area of the frame at a proximal end of the frame is greater than a cross-sectional area of the frame at a distal end of the frame.
For some applications, the expandable frame of the prosthetic valve is configured such that when the frame is in the non-constrained state thereof the frame defines a frustoconical shape.
For some applications, the expandable frame of the prosthetic valve is configured such that when the frame is in the non-constrained state thereof the frame defines a trumpet shape.
There is further provided, in accordance with some applications of the present invention, a method, including:
placing a prosthetic valve support at an annulus of a native atrioventricular valve of a patient, the prosthetic valve support defining an annular element that defines an inner cross-sectional area thereof;
placing into a ventricle of the patient, an expandable prosthetic valve,
determining a location anywhere along the portion at which to couple the expandable valve the prosthetic valve support; and
in response thereto,
aligning the location along the portion of the expandable frame with the annular element of the prosthetic valve support; and
coupling the expandable valve to the prosthetic valve support at the location, responsively to radial forces acted upon the valve support by the expandable frame, by facilitating expansion of the expandable frame, when the location along the portion is aligned with the annular element of the prosthetic valve support.
For some applications, placing the valve support at the annulus includes transcatheterally placing the valve support at the annulus in a collapsed state.
For some applications, the native atrioventricular valve includes a mitral valve, and placing the prosthetic valve into the ventricle includes placing into the ventricle a prosthetic valve that includes three prosthetic leaflets.
For some applications, placing the prosthetic valve support at the annulus includes placing an asymmetrically-shaped prosthetic valve support at the annulus.
For some applications, placing the prosthetic valve support at the annulus includes placing at the annulus an annular element that is shaped to define a hole, a center of the hole being disposed asymmetrically with respect to an outer perimeter of the annular element, the annular element being placed such that a center of the hole is disposed asymmetrically with respect to the annulus.
For some applications, the frame includes proximally-facing protrusions at a distal end thereof, the protrusions being configured to prevent proximal migration of the valve into an atrium, and coupling the expandable valve to the prosthetic valve support includes preventing proximal migration of the valve by coupling the valve to the valve support such that the leaflets are disposed at least partially between the protrusions and the valve support.
For some applications, coupling the expandable valve to the prosthetic valve support includes preventing the native leaflets from interfering with a left ventricular outflow tract of the patient.
For some applications, coupling the expandable valve to the prosthetic valve support includes allowing movement of the leaflets with respect to the frame while preventing the proximal migration of the valve.
For some applications, the frame includes first and second sets of one or more protrusions, each set of protrusions configured to ensnare a respective native leaflet of the native valve of the patient, the first set of protrusions being disposed within a first circumferential arc with respect to a longitudinal axis of the prosthetic valve, on a first side of a distal end of the frame, the second set of protrusions being disposed within a second circumferential arc with respect to the longitudinal axis of the prosthetic valve, on a second side of the distal end of the frame, the first and second sets being disposed so as to provide first and second gaps therebetween at the distal end of the frame, at least one of the gaps having a circumferential arc of at least 20 degrees, the method further including guiding the valve such that the first and second circumferential arcs are aligned with respective leaflets of the native valve and such that the first and second gaps are aligned with respective commissures of the native valve.
For some applications, facilitating expansion of the frame includes facilitating expansion of the frame to a maximum diameter of less than 25 mm.
For some applications, facilitating expansion of the frame includes facilitating expansion of the frame to a maximum diameter of more than 15 mm.
For some applications, facilitating expansion of the frame includes facilitating expansion of the frame to a maximum diameter of less than 20 mm.
For some applications, facilitating expansion of the frame includes facilitating expansion of the frame such that a cross-sectional area of the frame at a proximal end of the frame is greater than a cross-sectional area of the frame at a distal end of the frame.
For some applications, facilitating expansion of the frame includes facilitating expansion of the frame such that the frame defines a frustoconical shape.
For some applications, facilitating expansion of the frame includes facilitating expansion of the frame such that the frame defines a trumpet shape.
There is additionally provided, in accordance with some applications of the present invention, a method, including:
determining an indication of an area defined by an annulus of a native atrioventricular valve of a patient;
selecting a prosthetic valve support by determining that the prosthetic valve support defines an annular element that defines an inner cross-sectional area that is less than the area defined by the annulus;
placing the prosthetic valve support at the annulus of the native atrioventricular valve;
placing into a ventricle of the patient, an expandable prosthetic valve, the prosthetic valve including an expandable frame, and prosthetic valve leaflets coupled to the expandable frame;
coupling the expandable valve to the prosthetic valve support at the location, responsively to radial forces acted upon the valve support by the expandable frame, by facilitating expansion of the expandable frame,
a cross-sectional area defined by the expandable frame of the prosthetic valve being limited by the cross-sectional area defined by the annular element of the prosthetic valve support, such as to facilitate sealing of the native valve with respect to the prosthetic valve by facilitating closing of leaflets of the native valve around the prosthetic valve, upon deployment of the prosthetic valve.
For some applications, facilitating closing of leaflets of the native valve around the prosthetic valve includes facilitating sealing of the native valve at commissures of the native valve.
For some applications, facilitating closing of leaflets of the native valve around the prosthetic valve includes facilitating closing of the leaflets of the native valve around an outer surface of the expandable frame.
For some applications, placing the valve support at the annulus includes transcatheterally placing the valve support at the annulus in a collapsed state.
For some applications, the native atrioventricular valve includes a mitral valve, and placing the prosthetic valve into the ventricle includes placing into the ventricle a prosthetic valve that includes three prosthetic leaflets.
For some applications, placing the prosthetic valve support at the annulus includes placing an asymmetrically-shaped prosthetic valve support at the annulus.
For some applications, placing the prosthetic valve support at the annulus includes placing at the annulus an annular element that is shaped to define a hole, a center of the hole being disposed asymmetrically with respect to an outer perimeter of the annular element, the annular element being placed such that a center of the hole is disposed asymmetrically with respect to the annulus.
For some applications, the frame includes proximally-facing protrusions at a distal end thereof, the protrusions being configured to prevent proximal migration of the valve into an atrium, and coupling the expandable valve to the prosthetic valve support includes preventing proximal migration of the valve by coupling the valve to the valve support such that the leaflets are disposed at least partially between the protrusions and the valve support.
For some applications, coupling the expandable valve to the prosthetic valve support includes preventing the native leaflets from interfering with a left ventricular outflow tract of the patient.
For some applications, coupling the expandable valve to the prosthetic valve support includes allowing movement of the leaflets with respect to the frame while preventing proximal migration of the valve.
For some applications, the frame includes first and second sets of one or more protrusions, each set of protrusions configured to ensnare a respective native leaflet of the native valve of the patient, the first set of protrusions being disposed within a first circumferential arc with respect to a longitudinal axis of the prosthetic valve, on a first side of a distal end of the frame, the second set of protrusions being disposed within a second circumferential arc with respect to the longitudinal axis of the prosthetic valve, on a second side of the distal end of the frame, the first and second sets being disposed so as to provide first and second gaps therebetween at the distal end of the frame, at least one of the gaps having a circumferential arc of at least 20 degrees, the method further including guiding the valve such that the first and second circumferential arcs are aligned with respective leaflets of the native valve and such that the first and second gaps are aligned with respective commissures of the native valve.
For some applications, facilitating expansion of the frame includes facilitating expansion of the frame to a maximum diameter of less than 25 mm.
For some applications, facilitating expansion of the frame includes facilitating expansion of the frame to a maximum diameter of more than 15 mm.
For some applications, facilitating expansion of the frame includes facilitating expansion of the frame to a maximum diameter of less than 20 mm.
For some applications, facilitating expansion of the frame includes facilitating expansion of the frame such that a cross-sectional area of the frame at a proximal end of the frame is greater than a cross-sectional area of the frame at a distal end of the frame.
For some applications, facilitating expansion of the frame includes facilitating expansion of the frame such that the frame defines a frustoconical shape.
For some applications, facilitating expansion of the frame includes facilitating expansion of the frame such that the frame defines a trumpet shape.
There is additionally provided, in accordance with some applications of the present invention, a method, including:
placing a prosthetic valve support at an annulus of a native atrioventricular valve of a patient;
placing a prosthetic valve into a ventricle of the patient, the prosthetic valve including protrusions at a distal end thereof;
ensnaring one or more native leaflets of the native valve of the patient with the protrusions; and
coupling the prosthetic valve to the native valve,
There is further provided, in accordance with some applications of the present invention, a method, including:
determining an indication of an area defined by an annulus of a native atrioventricular valve of a patient;
selecting a prosthetic valve to be placed in the native valve by determining that the valve defines a cross-sectional area that is less than 90% of the area defined by the annulus; and
deploying the prosthetic valve at the native valve,
the selecting of the prosthetic valve facilitating sealing of the native valve with respect to the prosthetic valve by facilitating closing of leaflets of the native valve around the prosthetic valve, upon deployment of the prosthetic valve.
For some applications, selecting the prosthetic valve includes selecting a prosthetic valve having a material disposed on an outer surface thereof.
For some applications, selecting the prosthetic valve includes selecting a prosthetic valve having a material that prevents tissue growth disposed on an outer surface thereof.
For some applications, selecting the prosthetic valve includes selecting a prosthetic valve having a material that promotes tissue growth disposed on an outer surface thereof.
For some applications, selecting the prosthetic valve to be placed in the native valve includes determining that the valve defines a cross-sectional area that is less than 80% of the area defined by the annulus.
For some applications, selecting the prosthetic valve to be placed in the native valve includes determining that the valve defines a cross-sectional area that is less than 60% of the area defined by the annulus.
There is further provided, in accordance with some applications of the present invention, apparatus, including:
one or more valve support guide members configured to be delivered to one or more commissures of a native atrioventricular valve of a patient;
one or more valve support anchors configured to be anchored to the one or more commissures of the native valve;
a prosthetic valve support advanceable toward the native valve along the one or more valve support guide members and anchored to the native valve at at least the one or more commissures; and
a prosthetic valve configured to be coupled to the valve support.
For some applications, the valve support is collapsible for transcatheter delivery and expandable to contact the native atrioventricular valve.
For some applications, the one or more valve support anchors are configured to be anchored to the one or more commissures from ventricular surfaces thereof.
For some applications, the one or more valve support guide members includes one valve support guide member that is looped through first and second commissures of the atrioventricular valve in a manner in which a looped portion of the valve support guide member is disposed in a ventricle of the patient and first and second free ends of the valve support guide member are accessible from a site outside a body of the patient.
For some applications, the one or more valve support anchors includes first and second tissue anchors, the first and second tissue anchors being configured to be anchored to respective first and second commissures of the atrioventricular valve of the patient.
For some applications:
the one or more valve support anchors each include one or more radially-expandable prongs, and
the one or more prongs are disposed within a sheath in a compressed state prior to the anchoring, and exposed from within the sheath in order to expand and facilitate anchoring of the valve support anchor to the respective commissures.
For some applications, the prosthetic valve includes two or more prosthetic leaflets.
For some applications, the native atrioventricular valve includes a mitral valve, and the prosthetic valve includes three prosthetic leaflets.
For some applications, the valve support guide members are removable from the patient following the anchoring of the prosthetic valve support at the atrioventricular valve.
For some applications, the valve support is shaped so as to define a distal portion which is configured to push aside, at least in part, native leaflets of the valve of the patient.
For some applications, the one or more valve support anchors are advanceable along the one or more valve support guide members.
For some applications, the valve support is shaped so as to define one or more holes, the one or more holes being configured to facilitate slidable passage therethrough of a respective one of the one or more valve support guide members.
For some applications, the prosthetic valve is shaped so as to define one or more snares configured to ensnare one or more native leaflets of the native valve of the patient.
For some applications, the one or more valve support anchors includes one or more ventricular anchors, and the apparatus further includes one or more atrial anchors, each atrial anchor being configured to be advanced toward an atrial surface of the valve support and anchor in place the valve support in a vicinity of a respective one of the ventricular anchors.
For some applications, the apparatus includes one or more delivery lumens, and:
each one of the one or more valve support anchors is removably coupled to a distal end of a respective delivery lumen,
the delivery lumen is configured to facilitate advancement of the one or more anchors along the one or more guide members, and
the delivery lumen is decoupled from the anchor following the anchoring of the anchor to the one or more commissures.
For some applications, the one or more valve support guide members are removable from the body of the patient following the advancement of the one or more anchors along the one or more guide members.
For some applications:
the valve support is shaped so as to define one or more holes,
the one or more holes are configured to facilitate slidable passage therethrough of a respective one of the one or more delivery lumens, and
the one or more delivery lumens are decoupleable from the respective valve support anchor following the anchoring of the valve support to at least the one or more commissures.
For some applications, the one or more delivery lumens are removable from the body of the patient following the anchoring of the valve support to at least the one or more commissures.
For some applications, the valve support includes an annular element and a generally cylindrical element coupled to the annular element, the generally cylindrical element being configured to push aside native leaflets of the native valve, the cylindrical element has first and second ends and a cylindrical body that is disposed between the first and second ends.
For some applications, the apparatus includes one or more annular element tissue anchors, the annular element has an upper surface and a lower surface, and the lower surface is coupled to the one or more annular element tissue anchors, the one or more annular element tissue anchors being configured to puncture tissue of a native annulus of the native valve of the patient.
For some applications, one or more annular element tissue anchors includes a plurality of annular element tissue anchors positioned around the lower surface of the annular element.
For some applications, the one or more annular element tissue anchors includes a first commissural anchor configured to puncture tissue of the native valve at a first commissure thereof, and a second commissural anchor configured to puncture tissue of the native valve at a second commissure thereof.
For some applications, each anchor of the one or more annular element tissue anchors includes a distal pointed tip and one or more radially-expandable prongs, the prongs being configured to expand and facilitate anchoring of the anchor and restrict proximal motion of the annular element tissue anchor.
For some applications, the apparatus includes one or more prosthetic valve guide members reversibly couplable to the cylindrical element in a vicinity of the second end of the cylindrical element, the prosthetic valve guide members being configured to facilitate advancement of the prosthetic valve therealong and toward the valve support.
For some applications:
For some applications:
during the first period, the second end of the cylindrical element is disposed in an atrium of a heart of the patient and the annular element is positioned along an annulus of the native valve,
the prosthetic valve is advanceable along the one or more prosthetic valve guide members into a ventricle of the heart of the patient, and
in response to advancement of the prosthetic valve into the ventricle, the one or more prosthetic valve guide members are pulled into the ventricle and pull the second end and the body of the cylindrical element into the ventricle to invert the cylindrical element.
There is further provided, in accordance with some applications of the present invention, a method, including:
advancing one or more valve support guide members toward one or more commissures of a native atrioventricular valve of a patient;
advancing along the one or more valve support guide members one or more valve support tissue anchors toward the one or more commissures;
anchoring the one or more valve support tissue anchors to the one or more commissures;
anchoring a prosthetic valve support at the native atrioventricular valve by anchoring the prosthetic valve support at at least the one or more commissures; and
coupling a prosthetic valve to the prosthetic valve support.
For some applications, the method includes removing the one or more valve support guide members following the anchoring of the prosthetic valve support at the native atrioventricular valve.
For some applications, advancing the one or more valve support guide members toward the one or more commissures includes advancing one guide member and looping the one guide member through first and second commissures of the native atrioventricular valve in a manner in which a looped portion of the guide member is disposed in a ventricle of the patient and first and second free ends of the guide member are accessible from a site outside a body of the patient.
For some applications, anchoring the one or more valve support anchors includes anchoring the one or more valve support anchors to ventricular surface of the respective commissures of the native valve.
For some applications, anchoring the one or more valve support anchors includes anchoring first and second tissue anchors to respective first and second commissures of the native valve.
For some applications:
advancing along the one or more valve support guide members the one or more valve support tissue anchors includes advancing the one or more valve support tissue anchors within a sheath, and
anchoring the one or more valve support tissue anchors includes exposing the one or more valve support anchors from within the sheath and facilitating radial expansion of one or more radially-expandable prongs of the one or more anchors.
For some applications, coupling the prosthetic valve to the prosthetic valve support includes coupling a prosthetic valve having two or more leaflets.
For some applications, the native atrioventricular valve includes a mitral valve of the patient, and coupling the prosthetic valve to the prosthetic valve support includes coupling a prosthetic valve having three leaflets.
For some applications, anchoring the prosthetic valve support includes pushing aside, at least in part, native leaflets of the valve of the patient by at least a portion of the support.
For some applications, the prosthetic valve support is coupled to one or more annulus tissue anchors, and anchoring the prosthetic valve support includes pushing the one or more annulus tissue anchors into tissue of an annulus of the native valve.
For some applications, coupling the prosthetic valve to the prosthetic valve support includes ensnaring one or more native leaflets of the native valve of the patient by a portion of the prosthetic valve.
For some applications, the one or more valve support anchors includes one or more, ventricular anchors, and the method further includes advancing one or more atrial anchors to an atrial surface of the valve support, and anchoring in place the valve support in a vicinity of a respective one of the ventricular anchors.
For some applications, the method includes advancing the valve support along the one or more valve support guide members prior to the anchoring of the valve support.
For some applications, the valve support is shaped so as to define one or more holes, and advancing the valve support along the one or more valve support guide members includes threading the one or more valve support guide members through the one or more holes of the valve support and sliding the valve support along the one or more guide members.
For some applications, the method includes removing the one or more valve support guide members from a body of the patient following the anchoring of the valve support.
For some applications,
the valve support includes:
anchoring of the valve support, including anchoring the valve support in a manner in which:
For some applications, the method includes, following the anchoring, inverting the cylindrical element to pull the second end of the cylindrical element below the annular element and into a ventricle of the heart, in a manner in which the body of the cylindrical element is disposed below the annular element and pushes aside one or more native leaflets of the valve of the patient.
For some applications:
inverting the cylindrical element includes advancing the prosthetic valve along one or more prosthetic valve guide members reversibly coupled to the cylindrical element in a vicinity of the second end thereof,
advancing the prosthetic valve includes advancing the prosthetic valve into the ventricle to pull the prosthetic valve guide members and the second end of the cylindrical element into the ventricle, and
the method further includes following the advancing of the prosthetic valve into the ventricle, pulling proximally the prosthetic valve such that a proximal portion of the valve contacts the valve support.
For some applications, pulling the prosthetic valve proximally includes ensnaring the one or more leaflets of the valve by a portion of the prosthetic valve.
For some applications, advancing the one or more valve support anchors includes:
providing a respective delivery lumen coupled at a distal end thereof to each one of the one or more anchors,
advancing each delivery lumen along a respective one of the one or more valve support guide members,
facilitating anchoring of each one of the one or more anchors to the one or more commissures by the respective delivery lumen, and
decoupling the delivery lumen from each one of the one or more valve support anchors following the anchoring of the one or more valve support anchors.
For some applications, the method includes removing the one or more valve support guide members from a body of the patient following the anchoring of each one of the one or more valve support anchors to the one or more commissures.
For some applications, the method includes advancing the prosthetic valve support along the one or more delivery lumens prior to the anchoring the support at the native atrioventricular valve.
For some applications, the valve support is shaped so as to define one or more holes, and advancing the valve support along the one or more delivery lumens includes threading the one or more delivery lumens through the one or more holes of the valve support and sliding the valve support along the one or more delivery lumens.
For some applications, the method includes removing the one or more delivery lumens from a body of the patient following the anchoring the support at the atrioventricular valve.
There is additionally provided, in accordance with some applications of the present invention, apparatus including a valve support for receiving a prosthetic valve, the valve support including:
an annular element configured to be positioned along a native annulus of a native atrioventricular valve of a patient; and
a flexible generally cylindrical element configured to be positioned in the native atrioventricular valve of the patient and to push aside native leaflets of the native valve, the cylindrical element having first and second ends and a cylindrical body that is disposed between the first and second ends, and:
For some applications, the cylindrical element includes a flexible wireframe covered by a fabric.
For some applications, the valve support is collapsible for transcatheter delivery and expandable to contact the native atrioventricular valve.
For some applications, the annular element has an upper surface and a lower surface, the lower surface is coupled to one or more annular element tissue anchors configured to puncture tissue of the native annulus of the patient.
For some applications, the one or more annular element tissue anchors includes a plurality of annular element tissue anchors positioned around the lower surface of the annular element.
For some applications, the one or more annular element tissue anchors includes a first commissural annular element tissue anchor configured to puncture tissue of the native valve at a first commissure thereof, and a second commissural annular element tissue anchor configured to puncture tissue of the native valve at a second commissure thereof.
For some applications, each anchor of the one or more annular element tissue anchors includes a distal pointed tip and one or more radially-expandable prongs, the prongs being configured to expand and facilitate anchoring of the anchor and restrict proximal motion of the annular element tissue anchor.
For some applications, the apparatus includes one or more valve support guide members configured to be delivered to one or more commissures of the native atrioventricular valve of the patient, the one or more valve support guide members are configured to facilitate advancement of the valve support toward the native valve.
For some applications, the valve support is shaped so as to define one or more holes, the one or more holes configured to facilitate slidable passage therethrough of a respective one of the one or more valve support guide members.
For some applications, the one or more valve support guide members includes one valve support guide member that is looped through first and second commissures of the atrioventricular valve in a manner in which a looped portion of the valve support guide member is disposed in a ventricle of the patient and first and second free ends of the valve support guide member are accessible from a site outside a body of the patient.
For some applications, the apparatus includes one or more valve support tissue anchors configured to be advanceable along the one or more valve support guide members and anchored to the one or more commissures of the valve.
For some applications, the one or more valve support anchors includes one or more ventricular anchors, and the apparatus further includes one or more atrial anchors, each atrial anchor being configured to be advanced toward an atrial surface of the valve support and anchor in place the valve support in a vicinity of a respective one of the ventricular anchors.
For some applications, the valve support guide members are removable from the patient following the anchoring of the valve support at the atrioventricular valve.
For some applications, the one or more valve support anchors are configured to be anchored to the one or more commissures from ventricular surfaces thereof prior to advancement of the valve support.
For some applications, the one or more valve support tissue anchors includes first and second valve support tissue anchors, the first and second valve support tissue anchors being configured to be anchored to respective first and second commissures of the atrioventricular valve of the patient.
For some applications:
the one or more valve support tissue anchors each include one or more radially-expandable prongs, and
the one or more prongs are disposed within a sheath in a compressed state prior to the anchoring and exposed from within the sheath in order to expand and facilitate anchoring of the anchor to the respective commissures.
For some applications, the apparatus includes one or more prosthetic valve guide members reversibly couplable to the cylindrical element in a vicinity of the second end of the cylindrical element, the prosthetic valve guide members being configured to facilitate advancement of the prosthetic valve therealong and toward the valve support.
For some applications, the apparatus includes the prosthetic valve, and the prosthetic valve is couplable to the valve support.
For some applications:
during the first period, the second end of the cylindrical element is disposed in an atrium of a heart of the patient and the annular element is positioned along an annulus of the native valve,
the prosthetic valve is advanceable along the one or more prosthetic valve guide members into a ventricle of the heart of the patient, and
in response to advancement of the prosthetic valve into the ventricle, the one or more prosthetic valve guide members are pulled into the ventricle and pull the second end of the cylindrical element into the ventricle to invert the cylindrical element.
For some applications, the prosthetic valve is collapsible for transcatheter delivery and expandable when exposed from within a delivery catheter.
For some applications, the prosthetic valve includes two or more prosthetic leaflets.
For some applications, the native atrioventricular valve includes a mitral valve, and the prosthetic valve includes three prosthetic leaflets.
For some applications, the prosthetic valve guide members are removable from the patient following the anchoring of the prosthetic valve at the atrioventricular valve.
For some applications, the prosthetic valve is shaped so as to define one or more snares configured to ensnare one or more native leaflets of the native valve of the patient.
There is yet additionally provided, in accordance with some applications of the present invention, a method, including:
advancing toward a native atrioventricular valve of a heart of a patient, a valve support including:
anchoring the annular element to an annulus of the native atrioventricular valve, following the anchoring, the second end of the cylindrical element is disposed above the annular element in an atrium of the heart, in a manner in which the body of the cylindrical element is disposed above the annular element; and
following the anchoring, inverting the cylindrical element to pull the second end of the cylindrical element below the annular element and into a ventricle of the heart, in a manner in which the body of the cylindrical element is disposed below the annular element and pushes aside one or more native leaflets of the valve of the patient.
For some applications, anchoring the annular element to the annulus of the native atrioventricular valve includes:
advancing one or more valve support anchors that are distinct from the valve support toward one or more commissures of the heart, and
anchoring the annular element to the annulus using the one or more positioning anchors.
For some applications, the annular element is coupled to one or more annular element tissue anchors, and anchoring the annular element includes pushing the one or more annular element tissue anchors into tissue of the annulus.
For some applications:
inverting the cylindrical element includes advancing a prosthetic valve along one or more valve guide members reversibly coupled to the cylindrical element in a vicinity of the second end thereof,
advancing the prosthetic valve includes advancing the prosthetic valve into the ventricle to pull the guide members and the second end of the cylindrical element into the ventricle, and
the method further includes following the advancing of the prosthetic valve into the ventricle, pulling proximally the prosthetic valve such that a proximal portion of the valve contacts the valve support.
For some applications, pulling the prosthetic valve proximally includes ensnaring the one or more leaflets of the valve by a portion of the prosthetic valve.
There is also provided, in accordance with some applications of the present invention, apparatus including a valve support for receiving a prosthetic valve, the valve support including:
an annular element configured to be positioned along a native annulus of a native atrioventricular valve of a patient, the annular element having upper and lower surfaces; and
one or more annular element tissue anchors coupled to the lower surface of the annular element, the one or more annular element tissue anchors being configured to puncture tissue of the native annulus of the patient.
For some applications, the valve support is collapsible for transcatheter delivery and expandable to contact the native atrioventricular valve.
For some applications, the one or more annular element tissue anchors includes a plurality of annular element tissue anchors positioned around the lower surface of the annular element.
For some applications, the one or more annular element tissue anchors includes a first commissural annular element tissue anchor configured to puncture tissue of the native valve at a first commissure thereof, and a second commissural annular element tissue anchor configured to puncture tissue of the native valve at a second commissure thereof.
For some applications, each anchor of the one or more annular element tissue anchors includes a distal pointed tip and one or more radially-expandable prongs, the prongs being configured to expand and facilitate anchoring of the anchor and restrict proximal motion of the anchor.
For some applications, the apparatus includes one or more valve support guide members configured to be delivered to one or more commissures of the native atrioventricular valve of the patient, the one or more valve support guide members are configured to facilitate advancement of the valve support toward the native valve.
For some applications, the valve support is shaped so as to define one or more holes, the one or more holes configured to facilitate slidable passage therethrough of a respective one of the one or more valve support guide members.
For some applications, the one or more valve support guide members includes one valve support guide member that is looped through first and second commissures of the atrioventricular valve in a manner in which a looped portion of the valve support guide member is disposed in a ventricle of the patient and first and second free ends of the valve support guide member are accessible from a site outside a body of the patient.
For some applications, the apparatus includes one or more valve support tissue anchors that are distinct from the valve support and are configured to be advanceable along the one or more valve support guide members and anchored to the one or more commissures of the valve.
For some applications, the one or more valve support anchors includes one or more ventricular anchors, and the apparatus further includes one or more atrial anchors, each atrial anchor being configured to be advanced toward an atrial surface of the valve support and anchor in place the valve support in a vicinity of a respective one of the ventricular anchors.
For some applications, the one or more valve support guide members are removable from the patient following the anchoring of the valve support at the atrioventricular valve.
For some applications, the one or more valve support tissue anchors are configured to be anchored to the one or more commissures from ventricular surfaces thereof prior to advancement of the valve support.
For some applications, the one or more valve support tissue anchors includes first and second valve support tissue anchors, the first and second valve support tissue anchors being configured to be anchored to respective first and second commissures of the atrioventricular valve of the patient.
For some applications:
the one or more valve support tissue anchors each include one or more radially-expandable prongs, and
the one or more prongs are disposed within a sheath in a compressed state prior to the anchoring and exposed from within the sheath in order to expand and facilitate anchoring of the anchor to the respective commissures.
For some applications, the valve support further includes a flexible generally cylindrical element coupled to the annular element and configured to be positioned in the native atrioventricular valve of the patient and to push aside native leaflets of the native valve, the cylindrical element having first and second ends and a cylindrical body that is disposed between the first and second ends.
For some applications, the cylindrical element includes a flexible wireframe covered by a fabric.
For some applications, the apparatus includes one or more prosthetic valve guide members reversibly couplable to the cylindrical element in a vicinity of the second end of the cylindrical element, the prosthetic valve guide members being configured to facilitate advancement of the prosthetic valve therealong and toward the valve support.
For some applications, the apparatus includes the prosthetic valve, and the prosthetic valve is couplable to the valve support.
For some applications:
For some applications:
during the first period, the second end of the cylindrical element is disposed in an atrium of a heart of the patient,
the prosthetic valve is advanceable along the one or more prosthetic valve guide members into a ventricle of the heart of the patient, and
in response to advancement of the prosthetic valve into the ventricle, the one or more prosthetic valve guide members are pulled into the ventricle and pull the second end of the cylindrical element into the ventricle to invert the cylindrical element.
There is additionally provided, in accordance with some applications of the present invention, apparatus, including:
one or more valve support guide members configured to be delivered to one or more commissures of a native atrioventricular valve of a patient;
a prosthetic valve support configured to be advanced toward the native valve along the one or more valve support guide members and placed at the native valve;
a prosthetic valve configured to be coupled to the valve support; and
one or more sealing elements configured to facilitate sealing of an interface between the prosthetic valve support and the native valve.
For some applications, the sealing element includes a balloon disposed circumferentially around an outer surface of the prosthetic valve support.
For some applications, the sealing element includes one or more helices that are configured to facilitate sealing of commissures of the native valve with respect to the valve support by being wrapped around chordae tendineae of the native valve.
For some applications, the sealing element includes grasping elements that are configured to facilitate sealing of commissures of the native valve with respect to the valve support by grasping the commissures.
For some applications, the sealing element is configured to facilitate anchoring of the support to the native valve.
For some applications, the valve support is collapsible for transcatheter delivery and expandable to contact the native atrioventricular valve.
For some applications, the prosthetic valve includes two or more prosthetic leaflets.
For some applications, the native atrioventricular valve includes a mitral valve, and the prosthetic valve includes three prosthetic leaflets.
For some applications, the valve support guide members are removable from the patient following coupling of the prosthetic valve to the valve support.
For some applications, the valve support is shaped so as to define a distal portion which is configured to push aside, at least in part, native leaflets of the valve of the patient.
For some applications, the valve support is shaped so as to define one or more holes, the one or more holes being configured to facilitate slidable passage therethrough of a respective one of the one or more valve support guide members.
For some applications, the one or more valve support guide members includes one valve support guide member that is looped through first and second commissures of the atrioventricular valve in a manner in which a looped portion of the valve support guide member is disposed in a ventricle of the patient and first and second free ends of the valve support guide member are accessible from a site outside a body of the patient.
For some applications, the apparatus further includes:
a guide wire configured to be advanced, via the native atrioventricular valve, into a ventricle of the patient, and coupled to an inner wall of the patient's ventricle; and
a valve support guide member tube coupled to the guide wire,
and a distal portion of the valve support guide member is configured to loop through the valve support guide member tube, such that, in response to the valve support guide member being pushed distally, portions of the valve support guide member are pushed to respective commissures of the native valve.
For some applications, the prosthetic valve is shaped so as to define one or more protrusions configured to ensnare one or more native leaflets of the native valve of the patient.
For some applications, the protrusions are disposed in a sinusoidal configuration such that the protrusions conform with a saddle shape of the patient's native annulus.
For some applications, the protrusions are configured to prevent the native leaflets from interfering with a left ventricular outflow tract of the patient, by sandwiching the leaflets between the protrusions and the prosthetic valve support.
For some applications, the valve support includes:
a first end that is configured to be placed on an atrial side of a native atrioventricular valve of a patient; and
a second end that is configured, during a first period, to be disposed inside the patient's atrium, above the first end of the valve support,
the valve support being at least partially invertible in a manner in which, during a second period, the second end of the valve support is disposed at least partially inside a ventricle of the patient, below the first end of the valve support.
For some applications, the valve support includes an annular element and a generally cylindrical element coupled to the annular element, the generally cylindrical element being configured to push aside native leaflets of the native valve, and the cylindrical element has first and second ends and a cylindrical body that is disposed between the first and second ends.
For some applications, the sealing element includes a balloon disposed underneath the annular element and configured to facilitate sealing of an interface between the annular element and the native valve.
For some applications, the apparatus further includes one or more prosthetic valve guide members, the prosthetic valve guide members being configured to facilitate advancement of the prosthetic valve therealong and toward the valve support.
For some applications:
the first end of the cylindrical element is coupled to the annular element,
during a first period, the second end of the cylindrical element is disposed above the annular element in a manner in which the body of the cylindrical element is disposed above the annular element, and
the cylindrical element is invertible in a manner in which, during a second period, the second end of the cylindrical element is disposed below the annular element and the body of the cylindrical element is disposed below the annular element.
For some applications:
during the first period, the second end of the cylindrical element is disposed in an atrium of a heart of the patient and the annular element is positioned along an annulus of the native valve,
the prosthetic valve is advanceable along the one or more prosthetic valve guide members into a ventricle of the heart of the patient, and
in response to advancement of the prosthetic valve into the ventricle, the one or more prosthetic valve guide members are pulled into the ventricle and pull the second end and the body of the cylindrical element into the ventricle to invert the cylindrical element.
There is further provided, in accordance with some applications of the present invention, apparatus, including:
a prosthetic valve support configured to be advanced toward a native atrioventricular valve of a patient and placed at the native valve;
a prosthetic valve configured to be coupled to the valve support, the prosthetic valve being shaped so as to define first and second sets of one or more protrusions, each set of protrusions configured to ensnare a respective native leaflet of the native valve of the patient, the first set of protrusions being disposed within a first circumferential arc with respect to a longitudinal axis of the prosthetic valve, on a first side of a distal end of the prosthetic valve, the second set of protrusions being disposed within a second circumferential arc with respect to the longitudinal axis of the prosthetic valve, on a second side of the distal end of the prosthetic valve, the first and second sets being disposed so as to provide first and second gaps therebetween at the distal end of the prosthetic valve, at least one of the gaps having a circumferential arc of at least 20 degrees; and
one or more valve guide members configured to be delivered to one or more commissures of the native valve, and to guide the valve such that the first and second circumferential arcs are aligned with respective leaflets of the native valve and such that the first and second gaps are aligned with respective commissures of the native valve.
For some applications, the at least one of the gaps has a circumferential arc of at least 60 degrees.
For some applications, the first circumferential arc defines an angle of between 25 degrees and 90 degrees about the longitudinal axis of the prosthetic valve.
For some applications, the second circumferential arc defines an angle of between 25 degrees and 90 degrees about the longitudinal axis of the prosthetic valve.
For some applications, the first circumferential arc defines an angle of between 45 degrees and 75 degrees about the longitudinal axis of the prosthetic valve.
For some applications, the second circumferential arc defines an angle of between 45 degrees and 75 degrees about the longitudinal axis of the prosthetic valve.
There is additionally provided, in accordance with some applications of the present invention, a method, including:
determining an area defined by an annulus of a native atrioventricular valve of a patient;
selecting a prosthetic valve to be placed in the native valve by determining that the valve defines a cross-sectional area that is less than 90% of the area defined by the annulus; and
deploying the prosthetic valve at the native valve,
the selecting of the prosthetic valve facilitating sealing of the native valve with respect to the prosthetic valve by facilitating closing of leaflets of the native valve around the prosthetic valve, upon deployment of the prosthetic valve.
For some applications, selecting the prosthetic valve includes selecting a prosthetic valve having a material disposed on an outer surface thereof.
For some applications, selecting the prosthetic valve includes selecting a prosthetic valve having a material that prevents tissue growth disposed on an outer surface thereof.
For some applications, selecting the prosthetic valve includes selecting a prosthetic valve having a material that promotes tissue growth disposed on an outer surface thereof.
For some applications, selecting the prosthetic valve to be placed in the native valve includes determining that the valve defines a cross-sectional area that is less than 80% of the area defined by the annulus.
For some applications, selecting the prosthetic valve to be placed in the native valve includes determining that the valve defines a cross-sectional area that is less than 60% of the area defined by the annulus.
There is further provided, in accordance with some applications of the present invention, apparatus including:
a valve support for receiving a prosthetic valve, the valve support including:
For some applications, the valve support includes a flexible wireframe covered by a fabric.
For some applications, the valve support is collapsible for transcatheter delivery and expandable to contact the native atrioventricular valve.
For some applications, the valve support defines a surface that is an inner surface of the valve support during the first period, and an outer surface of the valve support during the second period, and the apparatus further includes a sealing material that is disposed on the surface, such that during the second period the sealing material facilitates sealing between the valve support and the native valve.
For some applications, the first end includes a coupling element configured to couple the valve support to tissue of the native valve on the atrial side of the native valve.
For some applications, the first end is shaped to define barbs that are configured to couple the valve support to tissue of the native valve on the atrial side of the native valve
For some applications, the valve support includes:
an annular element configured to be positioned along a native annulus of the native atrioventricular valve; and
a flexible generally cylindrical element configured to be positioned in the native atrioventricular valve of the patient and to push aside native leaflets of the native valve, the first end of the cylindrical element defining the first end of the valve support, and the first end of the cylindrical element being coupled to the annular element.
For some applications, the apparatus further includes one or more valve support guide members configured to be delivered to one or more commissures of the native atrioventricular valve of the patient, and the one or more valve support guide members are configured to facilitate advancement of the valve support toward the native valve.
For some applications, the valve support is shaped so as to define one or more holes, the one or more holes configured to facilitate slidable passage therethrough of a respective one of the one or more valve support guide members.
For some applications, the one or more valve support guide members includes one valve support guide member that is looped through first and second commissures of the atrioventricular valve in a manner in which a looped portion of the valve support guide member is disposed in a ventricle of the patient and first and second free ends of the valve support guide member are accessible from a site outside a body of the patient.
For some applications, the apparatus further includes:
a guide wire configured to be advanced, via the native atrioventricular valve, into a ventricle of the patient, and coupled to an inner wall of the patient's ventricle; and
a valve support guide member tube coupled to the guide wire,
and a distal portion of the valve support guide member is configured to loop through the valve support guide member tube, such that, in response to the valve support guide member being pushed distally, portions of the valve support guide member are pushed to respective commissures of the native valve.
For some applications, the apparatus further includes one or more prosthetic valve guide members reversibly couplable to the cylindrical element in a vicinity of the second end of the cylindrical element, the prosthetic valve guide members being configured to facilitate advancement of the prosthetic valve therealong and toward the valve support.
For some applications, the apparatus further includes the prosthetic valve, and the prosthetic valve is couplable to the valve support.
For some applications:
during the first period, the second end of the cylindrical element is disposed in an atrium of a heart of the patient and the annular element is positioned along an annulus of the native valve,
the prosthetic valve is advanceable along the one or more prosthetic valve guide members into a ventricle of the heart of the patient, and
in response to advancement of the prosthetic valve into the ventricle, the one or more prosthetic valve guide members are pulled into the ventricle and pull the second end of the cylindrical element into the ventricle to invert the cylindrical element.
For some applications, the apparatus further includes one or more sealing elements configured to facilitate sealing of an interface between the prosthetic valve support and the native valve.
For some applications, the sealing element includes a balloon disposed circumferentially around a surface of the prosthetic valve support.
For some applications, the sealing element includes one or more helices that are configured to facilitate sealing of commissures of the native valve with respect to the valve support by being wrapped around chordae tendineae of the native valve.
For some applications, the sealing element includes grasping elements that are configured to facilitate sealing of commissures of the native valve with respect to the valve support by grasping the commissures.
For some applications, the sealing element is configured to facilitate anchoring of the support to the native valve.
For some applications, the apparatus further includes the prosthetic valve, and the prosthetic valve is couplable to the valve support.
For some applications, the prosthetic valve is collapsible for transcatheter delivery and expandable when exposed from within a delivery catheter.
For some applications, the prosthetic valve includes two or more prosthetic leaflets.
For some applications, the native atrioventricular valve includes a mitral valve, and the prosthetic valve includes three prosthetic leaflets.
For some applications, the prosthetic valve is shaped so as to define one or more protrusions configured to ensnare one or more native leaflets of the native valve of the patient.
For some applications, the protrusions are disposed in a sinusoidal configuration such that the protrusions conform with a saddle shape of the patient's native annulus.
For some applications, the protrusions are configured to prevent the native leaflets from interfering with a left ventricular outflow tract of the patient, by sandwiching the leaflets between the protrusions and the prosthetic valve support.
There is further provided, in accordance with some applications of the present invention, apparatus, including:
a guide wire configured to be advanced into a patient's ventricle via a native atrioventricular valve of the patient, and coupled to an inner wall of the patient's ventricle;
a valve support guide member tube coupled to the guide wire;
a valve support guide member, a distal portion of the valve support guide member looping through the valve support guide member tube, such that, in response to the valve support guide member being pushed distally, portions of the valve support guide member are pushed to respective commissures of the native valve;
a prosthetic valve support configured to be advanced toward the commissures of the native valve along the valve support guide member portions; and
a prosthetic valve configured to be coupled to the valve support.
For some applications, first and second free ends of the valve support guide member are accessible from a site outside a body of the patient.
For some applications, the valve support includes:
an annular element configured to be positioned along a native annulus of the native atrioventricular valve; and
a generally cylindrical element configured to be positioned in the native atrioventricular valve of the patient and to push aside native leaflets of the native valve, the cylindrical element being coupled to the annular element, at a first end of the cylindrical element.
For some applications, the valve support is shaped so as to define one or more holes, the one or more holes configured to facilitate slidable passage therethrough of respective portions of the portions of the valve support guide member.
For some applications, the guide member is configured to facilitate advancement of the prosthetic valve therealong and toward the valve support.
For some applications, the prosthetic valve is collapsible for transcatheter delivery and expandable when exposed from within a delivery catheter.
For some applications, the prosthetic valve includes two or more prosthetic leaflets.
For some applications, the native atrioventricular valve includes a mitral valve, and the prosthetic valve includes three prosthetic leaflets.
For some applications, the guide member is removable from the patient following the coupling of the prosthetic valve to the valve support.
For some applications, the prosthetic valve is shaped so as to define one or more protrusions configured to ensnare one or more native leaflets of the native valve of the patient.
For some applications, the protrusions are disposed in a sinusoidal configuration such that the protrusions conform with a saddle shape of the patient's native annulus.
For some applications, the protrusions are configured to prevent the native leaflets from interfering with a left ventricular outflow tract of the patient, by sandwiching the leaflets between the protrusions and the prosthetic valve support.
For some applications, the apparatus further includes one or more sealing elements configured to facilitate sealing of an interface between the prosthetic valve support and the native valve.
For some applications, the sealing element includes a balloon disposed circumferentially around a surface of the prosthetic valve support.
For some applications, the sealing element includes one or more helices that are configured to facilitate sealing of commissures of the native valve with respect to the valve support by being wrapped around chordae tendineae of the native valve.
For some applications, the sealing element includes grasping elements that are configured to facilitate sealing of commissures of the native valve with respect to the valve support by grasping the commissures.
For some applications, the sealing element is configured to facilitate anchoring of the support to the native valve.
There is additionally provided, in accordance with some applications of the present invention, apparatus, including:
one or more valve guide members configured to be delivered to one or more commissures of a native atrioventricular valve of a patient;
a prosthetic valve configured to be advanced to be advanced toward the native valve along the one or more valve guide members and placed at the native valve at at least the one or more commissures; and
one or more proximally-facing grasping elements that are configured to facilitate sealing of commissures of the native valve with respect to the valve by:
For some applications, the grasping elements include two surfaces that are hingedly coupled to one another, and that are configured to facilitate the sealing of the commissures of the native valve with respect to the prosthetic valve by being closed about the hinge with respect to one another.
There is further provided, in accordance with some applications of the present invention, a method, including:
advancing one or more valve support guide members toward one or more commissures of a native atrioventricular valve of a patient;
placing a prosthetic valve support at the native atrioventricular valve by advancing the valve support along the one or more valve support guide members;
coupling a prosthetic valve to the prosthetic valve support; and
facilitating sealing of an interface between the prosthetic valve support and the native valve by deploying a sealing element in a vicinity of the interface.
There is additionally provided, in accordance with some applications of the present invention, a method including:
placing a first end of a prosthetic valve support on an atrial side of a native atrioventricular valve of a patient, such that a second end of the valve support is disposed, during a first period, inside the patient's atrium, above the first end of the valve support; and
subsequent to the placing of the valve support, inverting at least a portion of the valve support such that, during a second period, the second end of the valve support is disposed at least partially inside a ventricle of the patient, below the first end of the valve support.
There is additionally provided, in accordance with some applications of the present invention, a method, including:
advancing a guide wire, via a native atrioventricular valve, into a ventricle of the patient, a valve support guide member tube being coupled to the guide wire;
coupling a distal end of the guide wire to an inner wall of the patient's ventricle; and
causing portions of a valve support guide member to be pushed to respective commissures of the native valve, by pushing the guide member distally, a distal portion of the valve support guide member looping through the valve support guide member tube;
advancing a prosthetic valve support toward the commissures of the native valve along the valve support guide member portions; and
coupling a prosthetic valve to the valve support.
There is further provided, in accordance with some applications of the present invention, a method, including:
advancing one or more valve guide members toward one or more commissures of a native atrioventricular valve of a patient;
placing a prosthetic valve at the native atrioventricular valve by advancing the valve along the one or more valve guide members; and
facilitating sealing of commissures of the native valve with respect to the valve by:
The present invention will be more fully understood from the following detailed description of embodiments thereof, taken together with the drawings, in which:
Reference is now made to
It is noted that for applications in which valve 5 is the patient's mitral valve, first and second commissures 8 and 10 are the anterior and posterior commissures. For applications in which valve 5 is the patient's tricuspid valve (which includes three commissures), the first and second commissures are typically the anterior and posterior commissures of the tricuspid valve.
For some applications, guide members 21a and 21b comprise guide wires having a diameter of 0.035 inches.
The transcatheter procedure typically begins with the advancing of a semi-rigid guide wire into a right atrium 4 of the patient. The semi-rigid guide wire provides a guide for the subsequent advancement of a sheath 25 therealong and into the right atrium. Once sheath 25 has entered the right atrium, the semi-rigid guide wire is retracted from the patient's body. Sheath 25 typically comprises a 13-20 F sheath, although the size may be selected as appropriate for a given patient. Sheath 25 is advanced through vasculature into the right atrium using a suitable point of origin typically determined for a given patient. For example:
In some applications of the present invention, sheath 25 is advanced through the inferior vena cava of the patient and into the right atrium using a suitable point of origin typically determined for a given patient.
Sheath 25 is advanced distally until sheath 25 reaches the interatrial septum. For some applications, a resilient needle and a dilator (not shown) are advanced through the sheath and into the heart. In order to advance the sheath transseptally into the left atrium, the dilator is advanced to the septum, and the needle is pushed from within the dilator and is allowed to puncture the septum to create an opening that facilitates passage of the dilator and subsequently the sheath therethrough and into the left atrium. The dilator is passed through the hole in the septum created by the needle. Typically, the dilator is shaped to define a hollow shaft for passage along the needle, and the hollow shaft is shaped to define a tapered distal end. This tapered distal end is first advanced through the hole created by the needle. The hole is enlarged when the gradually increasing diameter of the distal end of the dilator is pushed through the hole in the septum.
The advancement of sheath 25 through the septum and into the left atrium is followed by the extraction of the dilator and the needle from within sheath 25.
As shown in
Anchors 30a and 30b, ribbed crimping structures 34, and the distal ends of surrounding sheaths 26a and 26b are advanced into ventricle 6. Subsequently, anchors 30a and 30b are pushed distally from within sheaths 26a and 26b, (or sheaths 26a and 26b are pulled proximally with respect to anchors 30a and 30b) to expose anchors 30a and 30b. As anchors 30a and 30b are exposed from within sheaths 26a and 26b, prongs 32 are free to expand, as shown in
As shown in
For some applications, following the anchoring of anchors 30a and 30b to commissures 8 and 10, respectively, guide members 21a and 21b are removed from the body of the patient.
Reference is now made to
It is to be noted that support 40 is slid along lumens 27a and 27b by way of illustration and not limitation. That is, for some applications, following the anchoring of anchors 30a and 30b to commissures 8 and 10, respectively, guide members 21a and 21b are not removed from the body of the patient, but rather lumens 27a and 27b are removed (e.g., by being decoupled from crimping structures 34) leaving behind anchors 30a and 30b and guide members 21a and 21b. Guide members 21a and 21b may then be threaded through holes 46a and 46b, respectively, and support 40 is slid along guide members 21a and 21b. In such a manner, guide members 21a and 21b function as valve support guide members.
Support 40 comprises a collapsible flexible support frame 48, which is at least partially covered by a covering 49. Support 40 is configured to be placed at native valve 5, such that cylindrical element 42 passes through the orifice of the native valve and extends towards, and, typically partially into, ventricle 6 (as shown in
For some applications, collapsible support frame 48 comprises a stent, which comprises a plurality of struts. The struts may comprise, for example, a metal such as nitinol or stainless steel. For some applications, frame 48 comprises a flexible metal, e.g., nitinol, which facilitates compression of support 40 within a delivery sheath or overtube 50. For some applications, covering 49 comprises a fabric, such as a woven fabric, e.g., Dacron. Covering 49 is typically configured to cover at least a portion of cylindrical element 42, and at least a portion of annular element 44. The covering may comprise a single piece, or a plurality of pieces sewn together.
As shown in
In
Responsively to the placement of valve support 40 at native valve 5, cylindrical element 42 is positioned partially within ventricle 6 and native leaflets 12 and 14 of native valve 5 are pushed aside.
As shown in section A-A, ribbed crimping structures 34 are shaped so as to define a plurality of male couplings. Locking crimping elements 64a and 64b each comprise a cylindrical element having an inner lumen that is shaped so as to surround a respective ribbed crimping structure 34. Each inner lumen of locking crimping elements 64a and 64b is shaped so as to define female couplings to receive the male couplings of ribbed crimping structure 34. The female couplings of locking crimping element 64 are directioned such that they facilitate distal advancement of locking crimping element 64 while restricting proximal advancement of locking crimping element 64. When the female couplings of locking crimping element 64 receive the male couplings of ribbed crimping structure 34, valve support 40 is locked in place from an atrial surface of valve 5. It is to be noted that for some applications, ribbed crimping elements 34 comprise female couplings, and locking crimping elements 64 comprise male couplings.
Reference is now made to
Following the placement of support 40 at annulus 11, pushing elements 52a and 52b and sheath or overtube 50 are removed from the body of the patient, leaving behind lumens 27a and 27b, as shown in
As shown in
Following the partial deployment of valve 80 in ventricle 6, overtube 70 is pulled proximally to pull valve 80 proximally such that cylindrical element 42 and/or annular element 44 of valve support 40 surrounds a proximal portion of prosthetic valve 80. Valve 80 has a tendency to expand such that valve 80 is held in place with respect to valve support 40 responsively to radial forces acted upon valve support 40 by prosthetic valve 80.
Valve 80 comprises a plurality of distal protrusions 84 (e.g., snares). When valve 80 is pulled proximally, as described hereinabove, protrusions 84 ensnare and engage the native leaflets of the atrioventricular valve. By the ensnaring of the native leaflets, protrusions 84 sandwich the native valve between protrusions 84 and prosthetic valve support 40. Such ensnaring helps further anchor prosthetic valve 80 to the native atrioventricular valve. The scope of the present invention includes using any sort of protrusions (e.g., hooks) that protrude from the distal end of expandable frame 79 of prosthetic valve 80 and that are configured such that the native valve is sandwiched between the protrusions and valve support 40. Typically, the protrusions cause sandwiching of the native valve leaflets, such that the leaflets do not interfere with the left ventricular outflow tract (LVOT).
For some applications, protrusions 84 are such as to (a) prevent proximal migration of the valve into the patient's atrium, while (b) allowing movement of the native leaflets with respect to the frame of the prosthetic valve. For example, the protrusions may have the aforementioned functionalities by having lengths of less than 5 mm, and/or by a total width of each set of protrusions corresponding to respective leaflets of the native valve being less than 5 mm. For example, the valve may include a single protrusion corresponding to each leaflet of the native valve, the width of each of the single protrusions being less than 1 mm. Thus, the valve may be stopped from proximally migrating into the atrium, by the protrusions preventing the distal end of the valve from migrating further proximally than edges of native leaflets of the valve. Furthermore, the protrusions may allow movement of the native leaflets with respect to the frame of the prosthetic valve by not generally squeezing the native leaflets between the protrusions and the frame of the valve. For some applications, by allowing movement of the native leaflets with respect to the frame of the prosthetic valve, sealing of the native leaflets against the outer surface of the frame of the prosthetic valve is facilitated, in accordance with the techniques described hereinbelow with reference to
For some applications, during the procedure, the prosthetic valve is pulled back proximally with respect to valve support, as described hereinabove. The prosthetic valve is pulled back to a position with respect to valve support that is such that protrusions 84 prevent the native leaflets from interfering with the LVOT, by sandwiching the native leaflets between the protrusions and the valve support, and/or by anchoring ends of the native leaflets as described hereinabove. The prosthetic valve is then deployed at this position.
For some applications, protrusions are disposed on the valve on the sides of the valve that are adjacent to the anterior and posterior leaflets of the native valve, and the valve does not includes protrusions on the portions of the valve that are adjacent to the commissures of the native valve, as described with reference to
Additionally, as shown in
Prosthetic valve 80 is configured for implantation in and/or at least partial replacement of a native atrioventricular valve 5 of the patient, such as a native mitral valve or a native tricuspid valve. Prosthetic valve 80 is configured to assume a collapsed state for minimally-invasive delivery to the diseased native valve, such as by percutaneous or transluminal delivery using one or more catheters.
Reference is now made to
Reference is now made to
Reference is now made to
Commissural helices 100a and 100b are typically placed at commissures 8 and 10 in a generally similar technique to that described with reference to anchors 30a and 30b. Typically, each helix 30a and 30b is reversibly coupled to a respective delivery lumen 27a and 27b. As described above, each delivery lumen 27 slides around a respective guide member 21, and a respective surrounding sheath 26a and 26b surrounds each delivery lumen 27a and 27b.
Commissural helices 100a and 100b (optionally, ribbed crimping structures 34), and the distal ends of surrounding sheaths 26a and 26b are advanced into ventricle 6. The helices are pushed out of the distal ends of surrounding sheaths 26a and 26b. Subsequently, the helices are rotated proximally such that the helices wrap around at least some chordae tendineae 102 of the patient. Following the advancement of the helices out of sheaths 26a and 26b, the sheaths are extracted. For some applications the helices are conical helices (as shown), and the wider end of the conical helix is disposed at the proximal end of the helix.
Subsequent to the placement of commissural helices 100a and 100b around the chordae tendineae, prosthetic valve support 40 is placed at annulus 11, in accordance with the techniques described hereinabove, and as shown in
Typically, commissural helices 100a and 100b facilitate sealing of native commissures 8 and 10, thereby reducing retrograde blood flow via the commissures, relative to retrograde blood flow in the absence of the helices. Further typically, the sealing of the native commissures facilitates anchoring of the prosthetic valve support to native valve 5.
Reference is now made to
Subsequent to the placement of grasping elements 106a and 106b distally to native commissures 8 and 10, prosthetic valve 80 is advanced toward native valve 5, as shown in
Typically, grasping elements 106a and 106b facilitate sealing of native commissures 8 and 10, thereby reducing retrograde blood flow via the commissures, relative to retrograde blood flow in the absence of the grasping elements. Further typically, the sealing of the native commissures facilitates anchoring of the prosthetic valve to native valve 5.
Although not shown, for some applications, prosthetic valve support 40 is used in addition to grasping elements 106a and 106b, in order to anchor prosthetic valve 80 to native valve 5. For some applications, the grasping elements are used to anchor and/or provide sealing for prosthetic valve support 40 (instead of, or in addition to, being used to anchor prosthetic valve 80, as shown). For such applications, generally similar techniques are used to those described with respect to the use of the grasping elements for anchoring the prosthetic valve, mutatis mutandis.
Reference is now made to
Reference is now made to
For some applications, an anchor 302 is advanced toward the vicinity of apex 304 of heart 2, via sheath 25, and is anchored to the vicinity of the apex, as shown in
As shown in
Subsequent to the placement of valve support 40 at the native valve, prosthetic atrioventricular valve 80 is coupled to valve support 40. For some applications, pushing elements 52a and 52b continue to push the valve support against the native valve, during the coupling of the prosthetic valve to the valve support. As described hereinabove, overtube 70 is advanced into ventricle 6, as shown in
As described hereinabove, valve 80 comprises a plurality of distal protrusions 84. When valve 80 is pulled proximally, as described hereinabove, protrusions 84 ensnare and engage the native leaflets of the atrioventricular valve. By the ensnaring of the native leaflets, protrusions 84 sandwich the native valve between protrusions 84 and prosthetic valve support 40. Such ensnaring helps further anchor prosthetic valve 80 to the native atrioventricular valve.
For some applications, as described hereinabove, protrusions 84 are such as to (a) prevent proximal migration of the valve into the patient's atrium, while (b) allowing movement of the native leaflets with respect to the frame of the prosthetic valve. For example, the protrusions may have the aforementioned functionalities by having lengths of less than 5 mm and/or by a total width of each set of protrusions corresponding to respective leaflets of the native valve being less than 5 mm. For example, the valve may include a single protrusion corresponding to each leaflet of the native valve, the width of each of the single protrusions being less than 1 mm. Thus, the valve may be stopped from proximally migrating into the atrium, by the protrusions preventing the distal end of the valve from migrating further proximally than edges of native leaflets of the valve. Furthermore, the protrusions may allow movement of the native leaflets with respect to the frame of the prosthetic valve by not generally squeezing the native leaflets between the protrusions and the frame of the valve. For some applications, by allowing movement of the native leaflets with respect to the frame of the prosthetic valve, sealing of the native leaflets against the outer surface of the frame of the prosthetic valve is facilitated, in accordance with the techniques described hereinbelow with reference to
Subsequent to the placement of the prosthetic valve at the native valve, sheath 25, overtube 70, pushing elements 52a and 52b, guide member 21, anchor 302, and guidewire 306 are removed from the patient's body, as shown in
Reference is now made to
Valve support 140 comprises an annular element 144 (that is identical to annular element 44 described hereinabove) and a cylindrical element 142. Cylindrical element 142 has a first end 150, a second end 152, and a cylindrical body 153 disposed between first and second ends 150 and 152. Cylindrical element 142 is attached to annular element 144 at first end 150 of cylindrical element 142.
During and following implantation of support 140 at annulus 11, as shown in
The configuration of valve support 140 as shown in
Reference is now made to
During a typical procedure, anchor 302 is advanced toward the vicinity of apex 304 of heart 2, via sheath 25, and is anchored to the vicinity of the apex, as shown in
Subsequent to the anchoring of first end 310 of prosthetic valve support 300 to native valve tissue (as shown in
Reference is now made to
The deployment of prosthetic valve 80 is generally similar to the techniques described hereinabove with reference to
As described hereinabove, for some applications, valve 80 comprises a plurality of distal protrusions 84. When valve 80 is pulled proximally, protrusions 84 ensnare and engage the native leaflets of the atrioventricular valve. By the ensnaring of the native leaflets, protrusions 84 sandwich the native valve between protrusions 84 and prosthetic valve support 300. Such ensnaring helps further anchor prosthetic valve 80 to the native atrioventricular valve.
For some applications, as described hereinabove, protrusions 84 are such as to (a) prevent proximal migration of the valve into the patient's atrium, while (b) allowing movement of the native leaflets with respect to the frame of the prosthetic valve. For example, the protrusions may have the aforementioned functionalities by having lengths of less than 5 mm, and/or by a total width of each set of protrusions corresponding to respective leaflets of the native valve being less than 5 mm. For example, the valve may include a single protrusion corresponding to each leaflet of the native valve, the width of each of the single protrusions being less than 1 mm. Thus, the valve may be stopped from proximally migrating into the atrium, by the protrusions preventing the distal end of the valve from migrating further proximally than edges of native leaflets of the valve. Furthermore, the protrusions may allow movement of the native leaflets with respect to the frame of the prosthetic valve by not generally squeezing the native leaflets between the protrusions and the frame of the valve. For some applications, by allowing movement of the native leaflets with respect to the frame of the prosthetic valve, sealing of the native leaflets against the outer surface of the frame of the prosthetic valve is facilitated, in accordance with the techniques described hereinbelow with reference to
Additionally, as shown in
Subsequent to the coupling of valve 80 to valve support 300, overtube 70, distal and proximal tensioning elements 308 and 311, and wires 309 are removed from the patient's body, via sheath 25. Typically, wires 309 are cut, in order to facilitate the removal of the wires from the patient's body. Guidewire 306 and anchor 302 are removed from the patient's body by detaching the anchor from apex 304, and withdrawing the anchor and the guidewire, via sheath 25.
Reference is now made to
For some applications, a prosthetic valve support 40 that includes annular element 44 (e.g., as shown in
Typically, placing a prosthetic valve inside the native valve with the dimensions of the native valve annulus, the prosthetic valve 80, and/or valve support 40 as described in the above paragraphs, facilitates sealing of the prosthetic valve with respect to the native valve. For some applications, the sealing is facilitated by the native leaflets being pushed against, and closing against, the outer surface of the frame of the valve during systole, in a similar manner to the manner in which native valve leaflets coapt during systole, in a healthy mitral valve. Typically, as the diameter of the prosthetic valve is increased, the length of the native leaflets that is pushed against the outer surface of the valve during systole is increased, thereby enhancing the sealing of the native leaflets with respect to the frame of the prosthetic valve. However, beyond a given diameter, as the diameter of the prosthetic valve is increased, the native valve leaflets are pushed apart at the commissures, thereby causing retrograde leakage of blood through the commissures. Therefore, in accordance with some applications of the present invention, prosthetic valve 80, and/or valve support 40 are chosen such that the cross-sectional area of the prosthetic valve when expanded inside the valve support is less than 90% (e.g., less than 80%, or less than 60%) of area A. Thus the valve support facilitates sealing of the prosthetic valve with respect to the native valve, by the native valve leaflets closing around the outer surface of the prosthetic valve, while not causing retrograde leakage of blood through the commissures.
For some applications, in order to facilitate the sealing of the native valve around the outer surface of the prosthetic valve, a material is placed on the outer surface of the prosthetic valve in order to provide a sealing interface between the prosthetic valve and the native valve. For example, a smooth material that prevents tissue growth (e.g., polytetrafluoroethylene (PTFE), and/or pericardium) may be placed on the outer surface of the prosthetic valve. Alternatively or additionally, a material that facilitates tissue growth (such as dacron) may be placed on the outer surface of the prosthetic valve, in order to (a) act as a sealing interface between the native valve and the prosthetic valve, and (b) facilitate tissue growth around the prosthetic valve to facilitate anchoring and/or sealing of the prosthetic valve.
Reference is now made to
For some applications, as described hereinabove, protrusions 84 are such as to (a) prevent proximal migration of the valve into the patient's atrium, while (b) allowing movement of the native leaflets with respect to the frame of the prosthetic valve. For example, the protrusions may have the aforementioned functionalities by having lengths of less than 5 mm, and/or by a total width of each set of protrusions corresponding to respective leaflets of the native valve being less than 5 mm. For example, the valve may include a single protrusion corresponding to each leaflet of the native valve, the width of each of the single protrusions being less than 1 mm. Thus, the valve may be stopped from proximally migrating into the atrium, by the protrusions preventing the distal end of the valve from migrating further proximally than edges of native leaflets of the valve. Furthermore, the protrusions may allow movement of the native leaflets with respect to the frame of the prosthetic valve by not generally squeezing the native leaflets between the protrusions and the frame of the valve. For some applications, by allowing movement of the native leaflets with respect to the frame of the prosthetic valve, sealing of the native leaflets against the outer surface of the frame of the prosthetic valve is facilitated, in accordance with the techniques described hereinabove with reference to
For some applications, a first set of protrusions 84 from the distal end of prosthetic valve 80 are disposed within a first circumferential arc with respect to a longitudinal axis of the prosthetic valve, on a first side of the distal end of the prosthetic valve, the first side of the distal end being configured to be placed adjacent to the anterior leaflet of the native valve. A second set of protrusions are disposed within a second circumferential arc with respect to a longitudinal axis of the prosthetic valve, on a second side of the distal end of the prosthetic valve, the second side of the distal end being configured to be placed adjacent to the posterior leaflet of the native valve.
The first and second sets of protrusions are disposed so as to provide first and second gaps therebetween at the distal end of the prosthetic valve. Typically, at least one of the gaps between the two sets of protrusions has a circumferential arc of at least 20 degrees (e.g., at least 60 degrees, or at least 100 degrees), and/or less than 180 degrees (e.g., less than 140 degrees), e.g., 60-180 degrees, or 100-140 degrees. Further typically, one or both of the first and second circumferential arcs defines an angle of at least 25 degrees (e.g., at least 45 degrees), and/or less than 90 degrees (e.g., less than 75 degrees), e.g., 25-90 degrees, or 45-75 degrees.
Valve guide members (e.g., guide members 21a and 21b, and/or delivery lumen 27a and 27b, as described hereinabove) are delivered to commissures of the native valve, and guide the valve such that the first and second circumferential arc are aligned with respective leaflets of the native valve and such that the first and second gaps are aligned with respective commissures of the native valve.
Reference is now made to
Reference is now made to
For some applications, the protrusions are configured to be distally-facing during the insertion of prosthetic valve 80 into the subject's left ventricle. For example, the valve may be inserted through overtube 70 (shown in
Typically, protrusions 84 are coupled to frame 79 of valve 80 at joints 412. For some applications, joints 412 are thinner than portions of the protrusions and of the frame surrounding the joints, as shown in
For some applications, barbs 416 extend from a proximal portion of expandable frame 79 of valve 80, as shown in
For some applications, the barbs are not generally used for coupling prosthetic valve support 80 to valve support 40. Rather, the prosthetic valve is coupled to the valve support by virtue of radial expansion of the prosthetic valve against annular element 44 of the valve support. Barbs 416 are used to prevent prosthetic valve from migrating distally into the patient's left ventricle, and/or to prevent valve support 40 from migrating proximally into the subject's left atrium.
For some applications (not shown), barbs protrude from coupling elements 81 of prosthetic valve 80, the barbs being generally similar in shape and function to that described with reference to barbs 416. For some applications (not shown), radially-inwardly facing barbs 45 protrude from annular element 44 of valve support 40, as shown in
For some applications, a proximal end of expandable frame 79 of prosthetic valve 80 defines a larger cross-section area than more distal portions of the expandable frame. For example, the expandable frame may have a frustoconical shape, the walls of the expandable frame diverging from a distal end of the frame to a proximal end of the frame. Alternatively, the expandable frame may have a trumpet shape (i.e., the frame may be generally tubular, with a dilated proximal end). For some applications, the larger cross-sectional area of the proximal end of the frame prevents the prosthetic valve from migrating distally into the patient's left ventricle, and/or prevents valve support 40 from migrating proximally into the subject's left atrium.
Reference is now made to
For some applications, annular element 44 is asymmetrical, as shown in
For some applications (not shown), radially-inwardly facing barbs 45 protrude from annular element 44 of valve support 40, as shown in
Typically, the annular element includes frame 48, the frame being covered at least in part with covering 49, e.g., fabric. Typically, the upper surface of annular element 44 is covered with fabric, for example, in order to provide a generally smooth surface for coming into contact with the patient's blood flow. Further typically, the lower surface of the annular element (i.e., the side of the annular element that is placed in contact with the native annulus) is not covered with fabric, for example, in order to reduce a crimped volume (or cross-sectional area) of the annular element, relative to the volume of the annular element if the lower surface of the annular element were covered in fabric. Typically, a thickness of the fabric layer is less than 0.2 mm, e.g., less than 0.1 mm, or less than 0.05 mm.
For some applications, the side of the annular element that is placed in contact with the native annulus is covered with the fabric, the fabric being configured to facilitate coupling of the annular element to the native annulus, by facilitating fibrosis at the interface between the annular element and the native annulus. For some applications, the upper surface of the annular element is not covered with fabric. For example, the upper surface may not be covered in fabric in order to reduce a crimped volume (or cross-sectional area) of the annular element, relative to the volume of the annular element if the upper surface of the annular element were covered in fabric.
For some applications, annular element 44 is not covered with fabric, and/or is not configured to form a seal against frame 79 of prosthetic valve 80. For some applications, the annular element is configured to allow leakage of blood between the annular element and frame 79 of prosthetic valve 80. For example, the annular element may be configured to allow leakage of blood through the interface between the annular element and the frame of the prosthetic valve, in order to accommodate a flow of blood between the patient's atrium and the patient's ventricle that is greater than can be accommodated by blood flowing through the leaflets of the prosthetic valve.
Reference is now made to
As shown in
Subsequent to the placement of valve support 40 at the native valve, prosthetic valve 80 is coupled to valve support 40. For some applications, pushing elements 52a, 52b, and 52c continue to push the valve support against the native valve, during the coupling of the prosthetic valve to the valve support.
Following the partial deployment of valve 80 in ventricle 6, overtube 70 is pulled proximally to pull valve 80 proximally such that annular element 44 of valve support 40 surrounds a proximal portion of prosthetic valve 80, as shown in
As described hereinabove, valve 80 comprises a plurality of distal protrusions 84. When valve 80 is pulled proximally, as described hereinabove, protrusions 84 ensnare and engage the native leaflets of the atrioventricular valve. By the ensnaring of the native leaflets, protrusions 84 sandwich the native valve between protrusions 84 and prosthetic valve support 40. Such ensnaring helps further anchor prosthetic valve 80 to the native atrioventricular valve.
It is noted with reference to
As described hereinabove, for some applications, expandable frame 79 of prosthetic valve 80 has a frustoconical shape. For some applications, the prosthetic valve is coupled to valve support 40 responsively to radial forces acted upon the valve support by the expandable frame, when a given location along portion L is aligned with annular element 44 of the prosthetic valve support. For some applications, the portion immediately proximal to the given location along portion L has a greater cross-sectional area than the frame at the given location, due to the frustoconical shape of the expandable frame. Typically, the greater cross-sectional area of the portion immediately proximal to the given location along portion L relative to the cross-sectional area of the frame at the given location, reduces distal migration of the prosthetic valve toward the subject's left ventricle.
For some applications, the location along portion L at which to couple prosthetic valve 80 to valve support 40 is selected, based upon a distance D between protrusions 84 and annular element 44 that would result from coupling the prosthetic valve to the annular element at that location. For example, the location along portion L at which to couple prosthetic valve 80 to valve support 40 may be selected, such that distance D is such as to anchor the prosthetic valve to the patient's native valve by squeezing the patient's native valve leaflets between the protrusions and the annular element, and/or by ensnaring the patient's chordae tendinae between the protrusions and the annular element. Alternatively or additionally, the location along portion L at which to couple prosthetic valve 80 to valve support 40 may be selected, such that distance D is such that protrusions 84 (a) prevent proximal migration of the valve into the patient's atrium, while (b) allowing movement of the native leaflets with respect to the frame of the prosthetic valve. Typically, the location along portion L is selected such that distance D is such that the valve may be stopped from proximally migrating into the atrium, by the protrusions preventing the distal end of the valve from migrating further proximally than edges of native leaflets of the valve, while the protrusions allow movement of the native leaflets with respect to the frame of the prosthetic valve by not generally squeezing the native leaflets between the protrusions and the frame of the valve. For some applications, by allowing movement of the native leaflets with respect to the frame of the prosthetic valve sealing of the native leaflets against the outer surface of the frame of the prosthetic valve is facilitated, in accordance with the techniques described hereinabove with reference to
Subsequent to the placement of the prosthetic valve at the native valve, overtube 70, and pushing elements 52a, 52b, and 52c are removed from the patient's body, as shown in
Reference is now made to
Typically, as shown in
As shown in
Typically, coupling mechanisms 502, which are used to couple looped guide member 21 to valve support 40 are detachable coupling mechanisms. For example, as shown, the coupling mechanism may include an anchor that defines an opening 506 through which suture 504 is inserted. The opening is closed by a closing member 508, such as a rod, or a wire. In order to detach the guide member from valve support, closing member 508 is opened (e.g., by being pulled proximally) such that suture 504 is released through opening 506.
Subsequent to the placement of valve support 40 at the native valve, prosthetic atrioventricular valve 80 is placed in ventricle 6, by advancing overtube 70 into the ventricle, as shown in
During the pulling back of overtube 70, looped guide member 21 is pushed distally, thereby pulling valve support 40 against the native annulus and providing a counter force against which overtube 70 is pulled back. For some applications, pulling of the valve support against the native annulus is such that it is not necessary to use anchors for anchoring the valve support to the native valve during the coupling of the prosthetic valve to the valve support. Alternatively, in addition to the pulling of the valve support against the native annulus providing a counter force against which the prosthetic valve is pulled, anchors are used to anchor the valve support to the native valve during the coupling of the prosthetic valve to the valve.
As described with reference to
Reference is now made to
Typically, valve leaflets 82 are selected to be used in prosthetic valve 80, the leaflets being sized such that both at diameter D2 (when the leaflets are constrained by expandable frame 79 but are not constrained by valve support 40) and at diameter D3 (when the leaflets are constrained by both expandable frame 79 and valve support 40), the valve leaflets fully coapt.
Reference is now made to
Reference is now made to
In
It is noted that, in general, prosthetic valve 80 is self-expandable. When the prosthetic valve is deployed (i.e., when the valve self-expands) inside the subject's heart, the expansion of the valve is typically constrained by valve support 40. Further typically, the expansion of the valve is not constrained by the native annulus.
For some application, by constraining the expansion of the prosthetic valve with the valve support, the deployed cross-sectional area of the prosthetic valve may be fixed at a given area, by using a valve support that defines a hole having the given cross-sectional area. As described hereinabove with reference to
For example, a valve support may be selected such that the valve support constrains the expansion of the prosthetic valve, when the cross-sectional area of the prosthetic valve is less than 90% (e.g., less than 80%, or less than 60%) of the area defined by the native annulus. As described hereinabove, for some applications, placing a prosthetic valve inside the native valve with the dimensions of the native valve annulus and the prosthetic valve being as described, facilitates sealing of the prosthetic valve with respect to the native valve, by the native valve leaflets closing around the outer surface of the prosthetic valve.
For some applications, the expansion of prosthetic valve 80 against valve support 40 couples the prosthetic valve to the valve support, and/or couples the valve and the valve support to the native mitral valve. Typically, the expansion of the prosthetic valve against the valve support couples the prosthetic valve to the valve support, and sandwiching of the native valve leaflets between protrusions from the distal end of the valve and the valve support couples the prosthetic valve and the valve support to the native valve.
Reference is now made to
The systems described herein are advanced toward valve 5 in a transcatheter procedure, as shown. It is to be noted, however, that the systems described herein may be advanced using any suitable procedure, e.g., minimally-invasively (e.g., via a transeptal, a transatrial, a transapical, and/or a transaortic approach), or using an open-heart procedure. It is to be further noted that valve supports and prosthetic valves herein may be used to replace native mitral valves or native tricuspid valves.
Reference is now made to
It will be appreciated by persons skilled in the art that the present invention is not limited to what has been particularly shown and described hereinabove. Rather, the scope of the present invention includes both combinations and subcombinations of the various features described hereinabove, as well as variations and modifications thereof that are not in the prior art, which would occur to persons skilled in the art upon reading the foregoing description.
The present application is a Continuation of U.S. Ser. No. 15/691,032 to HaCohen et al., filed Aug. 30, 2017 (now U.S. Pat. No. 10,512,456), which is a Continuation of U.S. patent application Ser. No. 14/689,608 to HaCohen et al., filed Apr. 17, 2015 (now U.S. Pat. No. 9,763,657), which is a Continuation of U.S. patent application Ser. No. 13/811,308 to Gross et al. (now U.S. Pat. No. 9,017,399), which is the US National Phase of PCT application IL2011/000582 to Gross et al., filed Jul. 21, 2011, which published as WO 2012/011108, and which: (1) claims priority and is a continuation-in-part of: (a) U.S. Ser. No. 12/840,463 to Hacohen et al., filed Jul. 21, 2010, entitled “Guide wires with commissural anchors to advance a prosthetic valve” (now U.S. Pat. No. 9,132,009), and(b) U.S. Ser. No. 13/033,852 to Gross et al., filed Feb. 24, 2011, entitled “Techniques for percutaneous mitral valve replacement and sealing” (now U.S. Pat. No. 8,992,604), which is a continuation-in-part of U.S. Ser. No. 12/840,463, and(2) claims priority from U.S. Provisional Patent Application 61/492,449 to Gross et al., filed Jun. 2, 2011, and entitled “Techniques for percutaneous mitral valve replacement and sealing.”
| Number | Name | Date | Kind |
|---|---|---|---|
| 3874388 | King et al. | Apr 1975 | A |
| 4222126 | Boretos et al. | Sep 1980 | A |
| 4261342 | Aranguren Guo | Apr 1981 | A |
| 4340091 | Skelton et al. | Jul 1982 | A |
| 4423525 | Vallana et al. | Jan 1984 | A |
| 4853986 | Allen | Aug 1989 | A |
| 4892541 | Alonso | Jan 1990 | A |
| 4972494 | White et al. | Nov 1990 | A |
| 5108420 | Marks | Apr 1992 | A |
| 5201757 | Heyn et al. | Apr 1993 | A |
| 5314473 | Godin | May 1994 | A |
| 5405378 | Strecker | Apr 1995 | A |
| 5443500 | Sigwart | Aug 1995 | A |
| 5607444 | Lam | Mar 1997 | A |
| 5607470 | Milo | Mar 1997 | A |
| 5647857 | Anderson et al. | Jul 1997 | A |
| 5713948 | Uflacker | Feb 1998 | A |
| 5716417 | Girard et al. | Feb 1998 | A |
| 5741297 | Simon | Apr 1998 | A |
| 5765682 | Bley et al. | Jun 1998 | A |
| 5776140 | Cottone | Jul 1998 | A |
| 5868777 | Lam | Feb 1999 | A |
| 5873906 | Lau et al. | Feb 1999 | A |
| 5954766 | Zadno-Azizi et al. | Sep 1999 | A |
| 5957949 | Leonhardt et al. | Sep 1999 | A |
| 5980565 | Jayaraman | Nov 1999 | A |
| 6010530 | Goicoechea | Jan 2000 | A |
| 6019787 | Richard et al. | Feb 2000 | A |
| 6042607 | Williamson, IV et al. | Mar 2000 | A |
| 6074417 | Peredo | Jun 2000 | A |
| 6113612 | Swanson et al. | Sep 2000 | A |
| 6120534 | Ruiz | Sep 2000 | A |
| 6126686 | Badylak et al. | Oct 2000 | A |
| 6152937 | Peterson et al. | Nov 2000 | A |
| 6165183 | Kuehn et al. | Dec 2000 | A |
| 6165210 | Lau et al. | Dec 2000 | A |
| 6172898 | Kajiyama | Jan 2001 | B1 |
| 6187020 | Zegdi et al. | Feb 2001 | B1 |
| 6193745 | Fogarty et al. | Feb 2001 | B1 |
| 6254609 | Vrba et al. | Jul 2001 | B1 |
| 6264700 | Kilcoyne et al. | Jul 2001 | B1 |
| 6287339 | Vazquez et al. | Sep 2001 | B1 |
| 6312465 | Griffin et al. | Nov 2001 | B1 |
| 6332893 | Mortier et al. | Dec 2001 | B1 |
| 6334873 | Lane et al. | Jan 2002 | B1 |
| 6346074 | Roth | Feb 2002 | B1 |
| 6350278 | Lenker et al. | Feb 2002 | B1 |
| 6352561 | Leopold et al. | Mar 2002 | B1 |
| 6391036 | Berg et al. | May 2002 | B1 |
| 6402780 | Williamson, IV et al. | Jun 2002 | B2 |
| 6409755 | Vrba | Jun 2002 | B1 |
| 6419696 | Ortiz et al. | Jul 2002 | B1 |
| 6428550 | Vargas et al. | Aug 2002 | B1 |
| 6440164 | DiMatteo et al. | Aug 2002 | B1 |
| 6454799 | Schreck | Sep 2002 | B1 |
| 6458153 | Bailey et al. | Oct 2002 | B1 |
| 6511491 | Grudem et al. | Jan 2003 | B2 |
| 6530952 | Vesely | Mar 2003 | B2 |
| 6540782 | Snyders | Apr 2003 | B1 |
| 6551350 | Thornton et al. | Apr 2003 | B1 |
| 6558418 | Inoue | May 2003 | B2 |
| 6569196 | Vesely | May 2003 | B1 |
| 6602263 | Swanson et al. | Aug 2003 | B1 |
| 6616675 | Evard et al. | Sep 2003 | B1 |
| 6652556 | VanTassel et al. | Nov 2003 | B1 |
| 6669724 | Park et al. | Dec 2003 | B2 |
| 6682558 | Tu et al. | Jan 2004 | B2 |
| 6699256 | Logan et al. | Mar 2004 | B1 |
| 6716244 | Klaco | Apr 2004 | B2 |
| 6719781 | Kim | Apr 2004 | B1 |
| 6730118 | Spenser et al. | May 2004 | B2 |
| 6730121 | Ortiz et al. | May 2004 | B2 |
| 6733525 | Yang et al. | May 2004 | B2 |
| 6752813 | Goldfarb et al. | Jun 2004 | B2 |
| 6764518 | Godin | Jul 2004 | B2 |
| 6767362 | Schreck | Jul 2004 | B2 |
| 6797002 | Spence et al. | Sep 2004 | B2 |
| 6821297 | Snyders | Nov 2004 | B2 |
| 6830585 | Artof et al. | Dec 2004 | B1 |
| 6830638 | Boylan et al. | Dec 2004 | B2 |
| 6893460 | Spenser et al. | May 2005 | B2 |
| 6926715 | Hauck et al. | Aug 2005 | B1 |
| 6951571 | Srivastava et al. | Oct 2005 | B1 |
| 6960217 | Bolduc | Nov 2005 | B2 |
| 6964684 | Ortiz et al. | Nov 2005 | B2 |
| 6974476 | McGuckin, Jr. et al. | Dec 2005 | B2 |
| 7011681 | Vesely | Mar 2006 | B2 |
| 7018406 | Seguin et al. | Mar 2006 | B2 |
| 7041132 | Quijano et al. | May 2006 | B2 |
| 7074236 | Rabkin et al. | Jul 2006 | B2 |
| 7077861 | Spence | Jul 2006 | B2 |
| 7101395 | Tremulis et al. | Sep 2006 | B2 |
| 7101396 | Artof et al. | Sep 2006 | B2 |
| 7137184 | Schreck | Nov 2006 | B2 |
| 7172625 | Shu et al. | Feb 2007 | B2 |
| 7198646 | Figulla et al. | Apr 2007 | B2 |
| 7201772 | Schwammenthal et al. | Apr 2007 | B2 |
| 7226467 | Lucatero et al. | Jun 2007 | B2 |
| 7226477 | Cox | Jun 2007 | B2 |
| 7261686 | Couvillon, Jr. | Aug 2007 | B2 |
| 7288097 | Séguin | Oct 2007 | B2 |
| 7288111 | Holloway et al. | Oct 2007 | B1 |
| 7316716 | Egan | Jan 2008 | B2 |
| 7318219 | Hall | Jan 2008 | B2 |
| 7329279 | Haug et al. | Feb 2008 | B2 |
| 7335213 | Hyde et al. | Feb 2008 | B1 |
| 7351256 | Hojeibane et al. | Apr 2008 | B2 |
| 7374573 | Gabbay | May 2008 | B2 |
| 7377938 | Sarac et al. | May 2008 | B2 |
| 7381218 | Schreck | Jun 2008 | B2 |
| 7404824 | Webler et al. | Jul 2008 | B1 |
| 7422603 | Lane | Sep 2008 | B2 |
| 7429269 | Schwammenthal et al. | Sep 2008 | B2 |
| 7442204 | Schwammenthal et al. | Oct 2008 | B2 |
| 7445630 | Lashinski et al. | Nov 2008 | B2 |
| 7455677 | Vargas et al. | Nov 2008 | B2 |
| 7455688 | Furst et al. | Nov 2008 | B2 |
| 7462162 | Phan et al. | Dec 2008 | B2 |
| 7481838 | Carpentier et al. | Jan 2009 | B2 |
| 7510575 | Spenser et al. | Mar 2009 | B2 |
| 7513909 | Lane et al. | Apr 2009 | B2 |
| 7524331 | Birdsall | Apr 2009 | B2 |
| 7527646 | Rahdert et al. | May 2009 | B2 |
| 7556632 | Zadno | Jul 2009 | B2 |
| 7556646 | Yang et al. | Jul 2009 | B2 |
| 7563267 | Goldfarb et al. | Jul 2009 | B2 |
| 7563273 | Goldfarb et al. | Jul 2009 | B2 |
| 7582111 | Krolik et al. | Sep 2009 | B2 |
| 7585321 | Cribier et al. | Sep 2009 | B2 |
| 7597711 | Drews et al. | Oct 2009 | B2 |
| 7608091 | Goldfarb et al. | Oct 2009 | B2 |
| 7611534 | Kapadia et al. | Nov 2009 | B2 |
| 7621948 | Hermann et al. | Nov 2009 | B2 |
| 7625403 | Krivoruchko et al. | Dec 2009 | B2 |
| 7632302 | Vreeman et al. | Dec 2009 | B2 |
| 7635329 | Goldfarb et al. | Dec 2009 | B2 |
| 7648528 | Styrc | Jan 2010 | B2 |
| 7655015 | Goldfarb et al. | Feb 2010 | B2 |
| 7682380 | Thornton et al. | Mar 2010 | B2 |
| 7708775 | Rowe et al. | May 2010 | B2 |
| 7717952 | Case et al. | May 2010 | B2 |
| 7717955 | Lane et al. | May 2010 | B2 |
| 7731741 | Eidenschink | Jun 2010 | B2 |
| 7736388 | Goldfarb et al. | Jun 2010 | B2 |
| 7748389 | Salahieh et al. | Jul 2010 | B2 |
| 7753922 | Starksen | Jul 2010 | B2 |
| 7753949 | Lamphere et al. | Jul 2010 | B2 |
| 7758595 | Allen et al. | Jul 2010 | B2 |
| 7758632 | Hojeibane et al. | Jul 2010 | B2 |
| 7758640 | Vesely | Jul 2010 | B2 |
| 7771467 | Svensson | Aug 2010 | B2 |
| 7771469 | Liddicoat | Aug 2010 | B2 |
| 7776083 | Vesely | Aug 2010 | B2 |
| 7780726 | Seguin | Aug 2010 | B2 |
| 7799069 | Bailey et al. | Sep 2010 | B2 |
| 7803181 | Furst et al. | Sep 2010 | B2 |
| 7811296 | Goldfarb et al. | Oct 2010 | B2 |
| 7811316 | Kalmann et al. | Oct 2010 | B2 |
| 7824442 | Salahieh et al. | Nov 2010 | B2 |
| 7837645 | Bessler et al. | Nov 2010 | B2 |
| 7837727 | Goetz et al. | Nov 2010 | B2 |
| 7842081 | Yadin | Nov 2010 | B2 |
| 7850725 | Vardi et al. | Dec 2010 | B2 |
| 7871432 | Bergin | Jan 2011 | B2 |
| 7871436 | Ryan et al. | Jan 2011 | B2 |
| 7887583 | Macoviak | Feb 2011 | B2 |
| 7892281 | Seguin et al. | Feb 2011 | B2 |
| 7896915 | Guyenot et al. | Mar 2011 | B2 |
| 7914544 | Nguyen et al. | Mar 2011 | B2 |
| 7914569 | Nguyen et al. | Mar 2011 | B2 |
| 7927370 | Webler et al. | Apr 2011 | B2 |
| 7942927 | Kaye et al. | May 2011 | B2 |
| 7947072 | Yang et al. | May 2011 | B2 |
| 7947075 | Goetz et al. | May 2011 | B2 |
| 7951195 | Antonsson et al. | May 2011 | B2 |
| 7955375 | Agnew | Jun 2011 | B2 |
| 7955377 | Melsheimer | Jun 2011 | B2 |
| 7955384 | Rafiee et al. | Jun 2011 | B2 |
| 7959666 | Salahieh et al. | Jun 2011 | B2 |
| 7959672 | Salahieh et al. | Jun 2011 | B2 |
| 7967833 | Sterman et al. | Jun 2011 | B2 |
| 7967857 | Lane | Jun 2011 | B2 |
| 7981151 | Rowe | Jul 2011 | B2 |
| 7981153 | Fogarty et al. | Jul 2011 | B2 |
| 7992567 | Hirotsuka et al. | Aug 2011 | B2 |
| 7993393 | Carpentier et al. | Aug 2011 | B2 |
| 8002825 | Letac et al. | Aug 2011 | B2 |
| 8002826 | Seguin | Aug 2011 | B2 |
| 8016877 | Seguin et al. | Sep 2011 | B2 |
| 8016882 | Macoviak et al. | Sep 2011 | B2 |
| 8021420 | Dolan | Sep 2011 | B2 |
| 8021421 | Fogarty et al. | Sep 2011 | B2 |
| 8025695 | Fogarty et al. | Sep 2011 | B2 |
| 8029518 | Goldfarb et al. | Oct 2011 | B2 |
| 8029557 | Sobrino-Serrano et al. | Oct 2011 | B2 |
| 8029564 | Johnson et al. | Oct 2011 | B2 |
| 8034104 | Carpentier et al. | Oct 2011 | B2 |
| 8038720 | Wallace et al. | Oct 2011 | B2 |
| 8043360 | McNamara et al. | Oct 2011 | B2 |
| 8048138 | Sullivan et al. | Nov 2011 | B2 |
| 8048140 | Purdy | Nov 2011 | B2 |
| 8048153 | Salahieh et al. | Nov 2011 | B2 |
| 8052592 | Goldfarb et al. | Nov 2011 | B2 |
| 8052741 | Bruszewski et al. | Nov 2011 | B2 |
| 8052749 | Salahieh et al. | Nov 2011 | B2 |
| 8057493 | Goldfarb et al. | Nov 2011 | B2 |
| 8057532 | Hoffman | Nov 2011 | B2 |
| 8057540 | Letac et al. | Nov 2011 | B2 |
| 8062355 | Figulla et al. | Nov 2011 | B2 |
| 8062359 | Marquez et al. | Nov 2011 | B2 |
| 8070708 | Rottenberg et al. | Dec 2011 | B2 |
| 8070800 | Lock et al. | Dec 2011 | B2 |
| 8070802 | Lamphere et al. | Dec 2011 | B2 |
| 8070804 | Hyde et al. | Dec 2011 | B2 |
| 8075611 | Millwee et al. | Dec 2011 | B2 |
| 8080054 | Rowe | Dec 2011 | B2 |
| 8083793 | Lane et al. | Dec 2011 | B2 |
| D652927 | Braido et al. | Jan 2012 | S |
| D653341 | Braido et al. | Jan 2012 | S |
| 8092518 | Schreck | Jan 2012 | B2 |
| 8092520 | Quadri | Jan 2012 | B2 |
| 8092521 | Figulla et al. | Jan 2012 | B2 |
| 8105377 | Liddicoat | Jan 2012 | B2 |
| 8109996 | Stacchino et al. | Feb 2012 | B2 |
| 8118866 | Hermann et al. | Feb 2012 | B2 |
| 8133270 | Kheradvar et al. | Mar 2012 | B2 |
| 8136218 | Millwee et al. | Mar 2012 | B2 |
| 8137398 | Tuval et al. | Mar 2012 | B2 |
| 8142492 | Forster et al. | Mar 2012 | B2 |
| 8142494 | Rahdert et al. | Mar 2012 | B2 |
| 8142496 | Berreklouw | Mar 2012 | B2 |
| 8142497 | Friedman | Mar 2012 | B2 |
| 8147504 | Ino et al. | Apr 2012 | B2 |
| 8157852 | Bloom et al. | Apr 2012 | B2 |
| 8157853 | Laske et al. | Apr 2012 | B2 |
| 8157860 | McNamara et al. | Apr 2012 | B2 |
| 8163008 | Wilson et al. | Apr 2012 | B2 |
| 8163014 | Lane et al. | Apr 2012 | B2 |
| D660433 | Braido et al. | May 2012 | S |
| D660967 | Braido et al. | May 2012 | S |
| 8167894 | Miles et al. | May 2012 | B2 |
| 8167932 | Bourang et al. | May 2012 | B2 |
| 8167935 | McGuckin, Jr. et al. | May 2012 | B2 |
| 8172896 | McNamara et al. | May 2012 | B2 |
| 8177836 | Lee et al. | May 2012 | B2 |
| 8182528 | Salahieh et al. | May 2012 | B2 |
| 8211169 | Lane et al. | Jul 2012 | B2 |
| 8216256 | Raschdorf, Jr. et al. | Jul 2012 | B2 |
| 8216301 | Bonhoeffer et al. | Jul 2012 | B2 |
| 8221492 | Case et al. | Jul 2012 | B2 |
| 8221493 | Boyle et al. | Jul 2012 | B2 |
| 8226710 | Nguyen et al. | Jul 2012 | B2 |
| 8231670 | Salahieh et al. | Jul 2012 | B2 |
| 8236045 | Benichou et al. | Aug 2012 | B2 |
| 8236049 | Rowe et al. | Aug 2012 | B2 |
| 8252042 | McNamara et al. | Aug 2012 | B2 |
| 8252051 | Chau et al. | Aug 2012 | B2 |
| 8252052 | Salahieh et al. | Aug 2012 | B2 |
| 8257390 | Carley et al. | Sep 2012 | B2 |
| 8267988 | Hamer et al. | Sep 2012 | B2 |
| 8277501 | Chalekian et al. | Oct 2012 | B2 |
| 8287591 | Keidar et al. | Oct 2012 | B2 |
| 8298280 | Yadin et al. | Oct 2012 | B2 |
| 8303653 | Bonhoeffer et al. | Nov 2012 | B2 |
| 8308798 | Pintor et al. | Nov 2012 | B2 |
| 8317853 | Agnew | Nov 2012 | B2 |
| 8317855 | Gregorich et al. | Nov 2012 | B2 |
| 8323335 | Rowe et al. | Dec 2012 | B2 |
| 8328868 | Paul et al. | Dec 2012 | B2 |
| 8337541 | Quadri et al. | Dec 2012 | B2 |
| 8343174 | Goldfarb et al. | Jan 2013 | B2 |
| 8343213 | Salahieh et al. | Jan 2013 | B2 |
| 8348999 | Kheradvar et al. | Jan 2013 | B2 |
| 8366767 | Zhang | Feb 2013 | B2 |
| 8372140 | Hoffman et al. | Feb 2013 | B2 |
| 8377119 | Drews et al. | Feb 2013 | B2 |
| 8398708 | Meiri et al. | Mar 2013 | B2 |
| 8403981 | Forster et al. | Mar 2013 | B2 |
| 8403983 | Quadri et al. | Mar 2013 | B2 |
| 8408214 | Spenser | Apr 2013 | B2 |
| 8414644 | Quadri et al. | Apr 2013 | B2 |
| 8425593 | Braido et al. | Apr 2013 | B2 |
| 8430934 | Das | Apr 2013 | B2 |
| 8444689 | Zhang | May 2013 | B2 |
| 8449599 | Chau et al. | May 2013 | B2 |
| 8449625 | Campbell et al. | May 2013 | B2 |
| 8454686 | Alkhatib | Jun 2013 | B2 |
| 8460365 | Haverkost et al. | Jun 2013 | B2 |
| 8474460 | Barrett et al. | Jul 2013 | B2 |
| 8500821 | Sobrino-Serrano et al. | Aug 2013 | B2 |
| 8512400 | Tran et al. | Aug 2013 | B2 |
| 8539662 | Stacchino et al. | Sep 2013 | B2 |
| 8545544 | Spenser et al. | Oct 2013 | B2 |
| 8551160 | Figulla et al. | Oct 2013 | B2 |
| 8551161 | Dolan | Oct 2013 | B2 |
| 8562672 | Bonhoeffer et al. | Oct 2013 | B2 |
| 8568475 | Nguyen et al. | Oct 2013 | B2 |
| 8579964 | Lane et al. | Nov 2013 | B2 |
| 8579965 | Bonhoeffer et al. | Nov 2013 | B2 |
| 8585755 | Chau et al. | Nov 2013 | B2 |
| 8585756 | Bonhoeffer et al. | Nov 2013 | B2 |
| 8591460 | Wilson et al. | Nov 2013 | B2 |
| 8591570 | Revuelta et al. | Nov 2013 | B2 |
| 8623075 | Murray, III et al. | Jan 2014 | B2 |
| 8623080 | Fogarty et al. | Jan 2014 | B2 |
| 8628569 | Benichou et al. | Jan 2014 | B2 |
| 8628570 | Seguin | Jan 2014 | B2 |
| 8628571 | Hacohen et al. | Jan 2014 | B1 |
| 8652203 | Quadri et al. | Feb 2014 | B2 |
| 8652204 | Quill et al. | Feb 2014 | B2 |
| 8657872 | Seguin | Feb 2014 | B2 |
| 8663322 | Keranen | Mar 2014 | B2 |
| 8673020 | Sobrino-Serrano et al. | Mar 2014 | B2 |
| 8679174 | Ottma et al. | Mar 2014 | B2 |
| 8685086 | Navia et al. | Apr 2014 | B2 |
| 8696742 | Pintor et al. | Apr 2014 | B2 |
| 8728155 | Montorfano et al. | May 2014 | B2 |
| 8734507 | Keranen | May 2014 | B2 |
| 8747460 | Tuval et al. | Jun 2014 | B2 |
| 8771345 | Tuval et al. | Jul 2014 | B2 |
| 8784472 | Eidenschink | Jul 2014 | B2 |
| 8784479 | Tuval et al. | Jul 2014 | B2 |
| 8784481 | Alkhatib et al. | Jul 2014 | B2 |
| 8795355 | Alkhatib | Aug 2014 | B2 |
| 8795356 | Quadri et al. | Aug 2014 | B2 |
| 8795357 | Yohanan et al. | Aug 2014 | B2 |
| 8801776 | House et al. | Aug 2014 | B2 |
| 8808366 | Braido et al. | Aug 2014 | B2 |
| 8840663 | Salahieh et al. | Sep 2014 | B2 |
| 8840664 | Karapetian et al. | Sep 2014 | B2 |
| 8845722 | Gabbay | Sep 2014 | B2 |
| 8852261 | White | Oct 2014 | B2 |
| 8852272 | Gross et al. | Oct 2014 | B2 |
| 8870948 | Erzberger et al. | Oct 2014 | B1 |
| 8870949 | Rowe | Oct 2014 | B2 |
| 8870950 | Hacohen | Oct 2014 | B2 |
| 8876800 | Behan | Nov 2014 | B2 |
| 8894702 | Quadri et al. | Nov 2014 | B2 |
| 8900294 | Paniagua et al. | Dec 2014 | B2 |
| 8900295 | Migliazza et al. | Dec 2014 | B2 |
| 8906083 | Obermiller et al. | Dec 2014 | B2 |
| 8911455 | Quadri et al. | Dec 2014 | B2 |
| 8911489 | Ben-Muvhar | Dec 2014 | B2 |
| 8911493 | Rowe et al. | Dec 2014 | B2 |
| 8932343 | Alkhatib et al. | Jan 2015 | B2 |
| 8961595 | Alkhatib | Feb 2015 | B2 |
| 8979922 | Jayasinghe et al. | Mar 2015 | B2 |
| 8986370 | Annest | Mar 2015 | B2 |
| 8986373 | Chau et al. | Mar 2015 | B2 |
| 8986375 | Garde et al. | Mar 2015 | B2 |
| 8992599 | Thubrikar et al. | Mar 2015 | B2 |
| 8992604 | Gross et al. | Mar 2015 | B2 |
| 8998982 | Richter et al. | Apr 2015 | B2 |
| 9005273 | Salahieh et al. | Apr 2015 | B2 |
| 9011468 | Ketai et al. | Apr 2015 | B2 |
| 9011527 | Li et al. | Apr 2015 | B2 |
| 9017399 | Gross et al. | Apr 2015 | B2 |
| D730520 | Braido et al. | May 2015 | S |
| D730521 | Braido et al. | May 2015 | S |
| 9023100 | Quadri et al. | May 2015 | B2 |
| 9034032 | McLean et al. | May 2015 | B2 |
| 9034033 | McLean et al. | May 2015 | B2 |
| 9039757 | McLean et al. | May 2015 | B2 |
| D732666 | Nguyen et al. | Jun 2015 | S |
| 9048676 | Tsuji et al. | Jun 2015 | B2 |
| 9050188 | Schweich, Jr. et al. | Jun 2015 | B2 |
| 9060858 | Thornton et al. | Jun 2015 | B2 |
| 9072603 | Tuval et al. | Jul 2015 | B2 |
| 9095434 | Rowe | Aug 2015 | B2 |
| 9119719 | Zipory et al. | Sep 2015 | B2 |
| 9125738 | Figulla et al. | Sep 2015 | B2 |
| 9125740 | Morriss et al. | Sep 2015 | B2 |
| 9132006 | Spenser et al. | Sep 2015 | B2 |
| 9132009 | Hacohen et al. | Sep 2015 | B2 |
| 9138312 | Tuval et al. | Sep 2015 | B2 |
| 9155619 | Liu et al. | Oct 2015 | B2 |
| 9173659 | Bodewadt et al. | Nov 2015 | B2 |
| 9173738 | Murray, III et al. | Nov 2015 | B2 |
| 9220594 | Braido et al. | Dec 2015 | B2 |
| 9226820 | Braido et al. | Jan 2016 | B2 |
| 9226839 | Kariniemi et al. | Jan 2016 | B1 |
| 9232995 | Kovalsky et al. | Jan 2016 | B2 |
| 9241790 | Lane et al. | Jan 2016 | B2 |
| 9241791 | Braido et al. | Jan 2016 | B2 |
| 9241792 | Benichou et al. | Jan 2016 | B2 |
| 9241794 | Braido et al. | Jan 2016 | B2 |
| 9248014 | Lane et al. | Feb 2016 | B2 |
| 9277994 | Miller et al. | Mar 2016 | B2 |
| 9289290 | Alkhatib et al. | Mar 2016 | B2 |
| 9289291 | Gorman, III et al. | Mar 2016 | B2 |
| 9295550 | Nguyen et al. | Mar 2016 | B2 |
| 9295551 | Straubinger et al. | Mar 2016 | B2 |
| 9295552 | McLean et al. | Mar 2016 | B2 |
| 9301836 | Buchbinder et al. | Apr 2016 | B2 |
| 9320591 | Bolduc | Apr 2016 | B2 |
| D755384 | Pesce et al. | May 2016 | S |
| 9326852 | Spenser | May 2016 | B2 |
| 9326876 | Acosta et al. | May 2016 | B2 |
| 9345573 | Nyuli et al. | May 2016 | B2 |
| 9387078 | Gross et al. | Jul 2016 | B2 |
| 9393110 | Levi et al. | Jul 2016 | B2 |
| 9421098 | Gifford, III et al. | Aug 2016 | B2 |
| 9427303 | Liddy et al. | Aug 2016 | B2 |
| 9427316 | Schweich, Jr. et al. | Aug 2016 | B2 |
| 9439757 | Wallace et al. | Sep 2016 | B2 |
| 9463102 | Kelly | Oct 2016 | B2 |
| 9474599 | Keranen | Oct 2016 | B2 |
| 9474638 | Robinson et al. | Oct 2016 | B2 |
| 9480559 | Vidlund et al. | Nov 2016 | B2 |
| 9492273 | Wallace et al. | Nov 2016 | B2 |
| 9498314 | Behan | Nov 2016 | B2 |
| 9532870 | Cooper et al. | Jan 2017 | B2 |
| 9554897 | Lane et al. | Jan 2017 | B2 |
| 9554899 | Granada et al. | Jan 2017 | B2 |
| 9561103 | Granada et al. | Feb 2017 | B2 |
| 9566152 | Schweich, Jr. et al. | Feb 2017 | B2 |
| 9597182 | Straubinger et al. | Mar 2017 | B2 |
| 9629716 | Seguin | Apr 2017 | B2 |
| 9662203 | Sheahan et al. | May 2017 | B2 |
| 9681952 | Hacohen | Jun 2017 | B2 |
| 9717591 | Chau et al. | Aug 2017 | B2 |
| 9743932 | Amplatz et al. | Aug 2017 | B2 |
| 9763657 | Hacohen et al. | Sep 2017 | B2 |
| 9763817 | Roeder | Sep 2017 | B2 |
| 9770256 | Cohen et al. | Sep 2017 | B2 |
| D800908 | Hariton et al. | Oct 2017 | S |
| 9788941 | Hacohen | Oct 2017 | B2 |
| 9895226 | Harari et al. | Feb 2018 | B1 |
| 9987132 | Hariton et al. | Jun 2018 | B1 |
| 10010414 | Cooper et al. | Jul 2018 | B2 |
| 10076415 | Metchik et al. | Sep 2018 | B1 |
| 10105222 | Metchik et al. | Oct 2018 | B1 |
| 10111751 | Metchik et al. | Oct 2018 | B1 |
| 10123873 | Metchik et al. | Nov 2018 | B1 |
| 10130475 | Metchik et al. | Nov 2018 | B1 |
| 10136993 | Metchik et al. | Nov 2018 | B1 |
| 10143552 | Wallace et al. | Dec 2018 | B2 |
| 10149761 | Granada et al. | Dec 2018 | B2 |
| 10154906 | Granada et al. | Dec 2018 | B2 |
| 10159570 | Metchik et al. | Dec 2018 | B1 |
| 10182908 | Tubishevitz et al. | Jan 2019 | B2 |
| 10226341 | Gross et al. | Mar 2019 | B2 |
| 10231837 | Metchik et al. | Mar 2019 | B1 |
| 10238493 | Metchik et al. | Mar 2019 | B1 |
| 10245143 | Gross et al. | Apr 2019 | B2 |
| 10245144 | Metchik et al. | Apr 2019 | B1 |
| 10258471 | Lutter et al. | Apr 2019 | B2 |
| 10292816 | Raanani et al. | May 2019 | B2 |
| 10299927 | McLean et al. | May 2019 | B2 |
| 10321995 | Christianson et al. | Jun 2019 | B1 |
| 10322020 | Lam et al. | Jun 2019 | B2 |
| 10327895 | Lozonschi et al. | Jun 2019 | B2 |
| 10335278 | McLean et al. | Jul 2019 | B2 |
| 10376361 | Gross et al. | Aug 2019 | B2 |
| 10507108 | Delgado et al. | Dec 2019 | B2 |
| 10507109 | Metchik et al. | Dec 2019 | B2 |
| 10512456 | Hacohen et al. | Dec 2019 | B2 |
| 10517719 | Miller et al. | Dec 2019 | B2 |
| 10524792 | Hemandez et al. | Jan 2020 | B2 |
| 10531866 | Hariton et al. | Jan 2020 | B2 |
| 10531872 | Hacohen et al. | Jan 2020 | B2 |
| 10548731 | Lashinski et al. | Feb 2020 | B2 |
| 10575948 | Iamberger et al. | Mar 2020 | B2 |
| 10595992 | Chambers | Mar 2020 | B2 |
| 10595997 | Metchik et al. | Mar 2020 | B2 |
| 10610358 | Vidlund et al. | Apr 2020 | B2 |
| 10646342 | Marr et al. | May 2020 | B1 |
| 10702385 | Hacohen et al. | Jul 2020 | B2 |
| 10758342 | Chau et al. | Sep 2020 | B2 |
| 10813760 | Metchik et al. | Oct 2020 | B2 |
| 10820998 | Marr et al. | Nov 2020 | B2 |
| 10842627 | Delgado et al. | Nov 2020 | B2 |
| 10856975 | Hariton et al. | Dec 2020 | B2 |
| 10856978 | Straubinger et al. | Dec 2020 | B2 |
| 10874514 | Dixon et al. | Dec 2020 | B2 |
| 10888425 | Delgado et al. | Jan 2021 | B2 |
| 10888644 | Ratz et al. | Jan 2021 | B2 |
| 10905552 | Dixon et al. | Feb 2021 | B2 |
| 10905554 | Cao | Feb 2021 | B2 |
| 10918483 | Metchik et al. | Feb 2021 | B2 |
| 10925732 | Delgado et al. | Feb 2021 | B2 |
| 10945843 | Delgado et al. | Mar 2021 | B2 |
| 10945844 | McCann et al. | Mar 2021 | B2 |
| 10993809 | McCann et al. | May 2021 | B2 |
| 11065114 | Raanani et al. | Jul 2021 | B2 |
| 11083582 | McCann et al. | Aug 2021 | B2 |
| 11147672 | McCann et al. | Oct 2021 | B2 |
| 11179240 | Delgado et al. | Nov 2021 | B2 |
| 11291545 | Hacohen | Apr 2022 | B2 |
| 11291546 | Gross et al. | Apr 2022 | B2 |
| 11291547 | Gross et al. | Apr 2022 | B2 |
| 20010002445 | Vesely | May 2001 | A1 |
| 20010005787 | Oz et al. | Jun 2001 | A1 |
| 20010021872 | Bailey et al. | Sep 2001 | A1 |
| 20010056295 | Solem | Dec 2001 | A1 |
| 20020013571 | Goldfarb et al. | Jan 2002 | A1 |
| 20020032481 | Gabbay | Mar 2002 | A1 |
| 20020099436 | Thornton et al. | Jul 2002 | A1 |
| 20020151970 | Garrison et al. | Oct 2002 | A1 |
| 20020177894 | Acosta et al. | Nov 2002 | A1 |
| 20030036791 | Philipp et al. | Feb 2003 | A1 |
| 20030050694 | Yang et al. | Mar 2003 | A1 |
| 20030060875 | Wittens | Mar 2003 | A1 |
| 20030069635 | Cartledge et al. | Apr 2003 | A1 |
| 20030074052 | Besselink | Apr 2003 | A1 |
| 20030083742 | Spence et al. | May 2003 | A1 |
| 20030105519 | Fasol et al. | Jun 2003 | A1 |
| 20030158578 | Pantages et al. | Aug 2003 | A1 |
| 20040010272 | Manetakis et al. | Jan 2004 | A1 |
| 20040030382 | St. Goar et al. | Feb 2004 | A1 |
| 20040039414 | Carley et al. | Feb 2004 | A1 |
| 20040093060 | Seguin et al. | May 2004 | A1 |
| 20040122503 | Campbell et al. | Jun 2004 | A1 |
| 20040122514 | Fogarty et al. | Jun 2004 | A1 |
| 20040133267 | Lane | Jul 2004 | A1 |
| 20040143315 | Bruun et al. | Jul 2004 | A1 |
| 20040176839 | Huynh et al. | Sep 2004 | A1 |
| 20040186558 | Pavcnik et al. | Sep 2004 | A1 |
| 20040186565 | Schreck | Sep 2004 | A1 |
| 20040186566 | Hindrichs et al. | Sep 2004 | A1 |
| 20040210244 | Vargas et al. | Oct 2004 | A1 |
| 20040210304 | Seguin et al. | Oct 2004 | A1 |
| 20040220593 | Greenhalgh | Nov 2004 | A1 |
| 20040225354 | Allen et al. | Nov 2004 | A1 |
| 20040236354 | Seguin | Nov 2004 | A1 |
| 20040249433 | Freitag | Dec 2004 | A1 |
| 20040260389 | Case et al. | Dec 2004 | A1 |
| 20040260394 | Douk et al. | Dec 2004 | A1 |
| 20050004668 | Aklog et al. | Jan 2005 | A1 |
| 20050021056 | St. Goar et al. | Jan 2005 | A1 |
| 20050027305 | Shiu et al. | Feb 2005 | A1 |
| 20050027348 | Case et al. | Feb 2005 | A1 |
| 20050038494 | Eidenschink | Feb 2005 | A1 |
| 20050055086 | Stobie | Mar 2005 | A1 |
| 20050075731 | Artof et al. | Apr 2005 | A1 |
| 20050080430 | Wright, Jr. et al. | Apr 2005 | A1 |
| 20050080474 | Andreas et al. | Apr 2005 | A1 |
| 20050085900 | Case et al. | Apr 2005 | A1 |
| 20050137686 | Salahieh et al. | Jun 2005 | A1 |
| 20050137688 | Salahieh et al. | Jun 2005 | A1 |
| 20050137689 | Salahieh et al. | Jun 2005 | A1 |
| 20050137690 | Salahieh et al. | Jun 2005 | A1 |
| 20050137691 | Salahieh et al. | Jun 2005 | A1 |
| 20050137692 | Haug et al. | Jun 2005 | A1 |
| 20050137695 | Salahieh et al. | Jun 2005 | A1 |
| 20050137697 | Salahieh et al. | Jun 2005 | A1 |
| 20050143809 | Salahieh et al. | Jun 2005 | A1 |
| 20050154443 | Linder et al. | Jul 2005 | A1 |
| 20050182486 | Gabbay | Aug 2005 | A1 |
| 20050197695 | Stacchino et al. | Sep 2005 | A1 |
| 20050203549 | Realyvasquez | Sep 2005 | A1 |
| 20050203618 | Sharkawy et al. | Sep 2005 | A1 |
| 20050216079 | MaCoviak | Sep 2005 | A1 |
| 20050234508 | Cummins et al. | Oct 2005 | A1 |
| 20050240200 | Bergheim | Oct 2005 | A1 |
| 20050251251 | Cribier | Nov 2005 | A1 |
| 20050256566 | Gabbay | Nov 2005 | A1 |
| 20050267573 | Macoviak et al. | Dec 2005 | A9 |
| 20060004439 | Spenser et al. | Jan 2006 | A1 |
| 20060004469 | Sokel | Jan 2006 | A1 |
| 20060015171 | Armstrong | Jan 2006 | A1 |
| 20060020275 | Goldfarb et al. | Jan 2006 | A1 |
| 20060020327 | Lashinski et al. | Jan 2006 | A1 |
| 20060020333 | Lashinski | Jan 2006 | A1 |
| 20060041189 | Vancaillie | Feb 2006 | A1 |
| 20060047297 | Case | Mar 2006 | A1 |
| 20060052867 | Revuelta et al. | Mar 2006 | A1 |
| 20060089627 | Burnett et al. | Apr 2006 | A1 |
| 20060111773 | Rittgers et al. | May 2006 | A1 |
| 20060116750 | Hebert et al. | Jun 2006 | A1 |
| 20060135964 | Vesely | Jun 2006 | A1 |
| 20060155357 | Melsheimer | Jul 2006 | A1 |
| 20060178700 | Quinn | Aug 2006 | A1 |
| 20060178740 | Stacchino et al. | Aug 2006 | A1 |
| 20060184203 | Martin et al. | Aug 2006 | A1 |
| 20060190036 | Wendel et al. | Aug 2006 | A1 |
| 20060190038 | Carley et al. | Aug 2006 | A1 |
| 20060195183 | Navia et al. | Aug 2006 | A1 |
| 20060195184 | Lane et al. | Aug 2006 | A1 |
| 20060201519 | Frazier et al. | Sep 2006 | A1 |
| 20060212111 | Case et al. | Sep 2006 | A1 |
| 20060216404 | Seyler et al. | Sep 2006 | A1 |
| 20060229708 | Powell et al. | Oct 2006 | A1 |
| 20060241656 | Starksen et al. | Oct 2006 | A1 |
| 20060241745 | Solem | Oct 2006 | A1 |
| 20060241748 | Lee et al. | Oct 2006 | A1 |
| 20060247680 | Amplatz et al. | Nov 2006 | A1 |
| 20060253191 | Salahieh et al. | Nov 2006 | A1 |
| 20060259136 | Nguyen et al. | Nov 2006 | A1 |
| 20060259137 | Artof et al. | Nov 2006 | A1 |
| 20060271166 | Thill et al. | Nov 2006 | A1 |
| 20060271171 | McQuinn et al. | Nov 2006 | A1 |
| 20060282150 | Olson et al. | Dec 2006 | A1 |
| 20060287719 | Rowe et al. | Dec 2006 | A1 |
| 20070016286 | Herrmann et al. | Jan 2007 | A1 |
| 20070016288 | Gurskis et al. | Jan 2007 | A1 |
| 20070027528 | Agnew | Feb 2007 | A1 |
| 20070027549 | Godin | Feb 2007 | A1 |
| 20070038293 | St. Goar et al. | Feb 2007 | A1 |
| 20070038295 | Case et al. | Feb 2007 | A1 |
| 20070043435 | Seguin | Feb 2007 | A1 |
| 20070055340 | Pryor | Mar 2007 | A1 |
| 20070056346 | Spenser et al. | Mar 2007 | A1 |
| 20070078510 | Ryan | Apr 2007 | A1 |
| 20070112422 | Dehdashtian | May 2007 | A1 |
| 20070118141 | Davidson | May 2007 | A1 |
| 20070162103 | Case et al. | Jul 2007 | A1 |
| 20070162107 | Haug et al. | Jul 2007 | A1 |
| 20070162111 | Fukamachi et al. | Jul 2007 | A1 |
| 20070173932 | Cali et al. | Jul 2007 | A1 |
| 20070197858 | Goldfarb et al. | Aug 2007 | A1 |
| 20070198077 | Cully et al. | Aug 2007 | A1 |
| 20070198097 | Zegdi | Aug 2007 | A1 |
| 20070213810 | Newhauser et al. | Sep 2007 | A1 |
| 20070213813 | Von Segesser et al. | Sep 2007 | A1 |
| 20070219630 | Chu | Sep 2007 | A1 |
| 20070225759 | Thommen et al. | Sep 2007 | A1 |
| 20070225760 | Moszner et al. | Sep 2007 | A1 |
| 20070233186 | Meng | Oct 2007 | A1 |
| 20070233237 | Krivoruchko | Oct 2007 | A1 |
| 20070239272 | Navia et al. | Oct 2007 | A1 |
| 20070239273 | Allen | Oct 2007 | A1 |
| 20070244546 | Francis | Oct 2007 | A1 |
| 20070255400 | Parravicini et al. | Nov 2007 | A1 |
| 20080004688 | Spenser et al. | Jan 2008 | A1 |
| 20080004697 | Lichtenstein et al. | Jan 2008 | A1 |
| 20080051703 | Thornton et al. | Feb 2008 | A1 |
| 20080065204 | Macoviak et al. | Mar 2008 | A1 |
| 20080071361 | Tuval et al. | Mar 2008 | A1 |
| 20080071363 | Tuval et al. | Mar 2008 | A1 |
| 20080071366 | Tuval | Mar 2008 | A1 |
| 20080071369 | Tuval et al. | Mar 2008 | A1 |
| 20080077235 | Kirson | Mar 2008 | A1 |
| 20080082083 | Forde et al. | Apr 2008 | A1 |
| 20080082159 | Tseng et al. | Apr 2008 | A1 |
| 20080082166 | Styrc et al. | Apr 2008 | A1 |
| 20080086164 | Rowe | Apr 2008 | A1 |
| 20080086204 | Rankin | Apr 2008 | A1 |
| 20080091261 | Long et al. | Apr 2008 | A1 |
| 20080097595 | Gabbay | Apr 2008 | A1 |
| 20080132989 | Snow et al. | Jun 2008 | A1 |
| 20080140003 | Bei et al. | Jun 2008 | A1 |
| 20080147182 | Righini et al. | Jun 2008 | A1 |
| 20080161910 | Revuelta et al. | Jul 2008 | A1 |
| 20080167705 | Agnew | Jul 2008 | A1 |
| 20080167714 | St. Goar et al. | Jul 2008 | A1 |
| 20080188929 | Schreck | Aug 2008 | A1 |
| 20080195200 | Vidlund et al. | Aug 2008 | A1 |
| 20080200980 | Robin et al. | Aug 2008 | A1 |
| 20080208328 | Antocci et al. | Aug 2008 | A1 |
| 20080208332 | Lamphere et al. | Aug 2008 | A1 |
| 20080221672 | Lamphere et al. | Sep 2008 | A1 |
| 20080234814 | Salahieh et al. | Sep 2008 | A1 |
| 20080243245 | Thambar et al. | Oct 2008 | A1 |
| 20080255580 | Hoffman et al. | Oct 2008 | A1 |
| 20080262609 | Gross et al. | Oct 2008 | A1 |
| 20080269879 | Sathe et al. | Oct 2008 | A1 |
| 20080281411 | Berreklouw | Nov 2008 | A1 |
| 20080294234 | Hartley et al. | Nov 2008 | A1 |
| 20090005863 | Goetz et al. | Jan 2009 | A1 |
| 20090036966 | O'Connor et al. | Feb 2009 | A1 |
| 20090054969 | Salahieh et al. | Feb 2009 | A1 |
| 20090082844 | Zacharias et al. | Mar 2009 | A1 |
| 20090088836 | Bishop et al. | Apr 2009 | A1 |
| 20090099554 | Forster et al. | Apr 2009 | A1 |
| 20090099650 | Bolduc et al. | Apr 2009 | A1 |
| 20090112159 | Slattery et al. | Apr 2009 | A1 |
| 20090125098 | Chuter | May 2009 | A1 |
| 20090157175 | Benichou | Jun 2009 | A1 |
| 20090163934 | Raschdorf, Jr. et al. | Jun 2009 | A1 |
| 20090171363 | Chocron | Jul 2009 | A1 |
| 20090177278 | Spence | Jul 2009 | A1 |
| 20090210052 | Forster et al. | Aug 2009 | A1 |
| 20090222081 | Linder et al. | Sep 2009 | A1 |
| 20090240320 | Tuval et al. | Sep 2009 | A1 |
| 20090241656 | Jacquemin | Oct 2009 | A1 |
| 20090259306 | Rowe | Oct 2009 | A1 |
| 20090264859 | Mas | Oct 2009 | A1 |
| 20090264994 | Saadat | Oct 2009 | A1 |
| 20090276040 | Rowe et al. | Nov 2009 | A1 |
| 20090281619 | Le et al. | Nov 2009 | A1 |
| 20090287304 | Dahlgren et al. | Nov 2009 | A1 |
| 20090299449 | Styrc | Dec 2009 | A1 |
| 20090306768 | Quadri et al. | Dec 2009 | A1 |
| 20090319037 | Rowe et al. | Dec 2009 | A1 |
| 20100022823 | Goldfarb et al. | Jan 2010 | A1 |
| 20100023117 | Yoganathan et al. | Jan 2010 | A1 |
| 20100023120 | Holecek et al. | Jan 2010 | A1 |
| 20100036479 | Hill et al. | Feb 2010 | A1 |
| 20100049313 | Alon et al. | Feb 2010 | A1 |
| 20100069852 | Kelley | Mar 2010 | A1 |
| 20100076548 | Konno | Mar 2010 | A1 |
| 20100100167 | Bortlein et al. | Apr 2010 | A1 |
| 20100114299 | Ben Muvhar et al. | May 2010 | A1 |
| 20100131054 | Tuval et al. | May 2010 | A1 |
| 20100137979 | Tuval et al. | Jun 2010 | A1 |
| 20100160958 | Clark | Jun 2010 | A1 |
| 20100161036 | Pintor et al. | Jun 2010 | A1 |
| 20100161042 | Maisano et al. | Jun 2010 | A1 |
| 20100174363 | Castro | Jul 2010 | A1 |
| 20100179643 | Shalev | Jul 2010 | A1 |
| 20100179648 | Richter et al. | Jul 2010 | A1 |
| 20100179649 | Richter et al. | Jul 2010 | A1 |
| 20100217382 | Chau et al. | Aug 2010 | A1 |
| 20100222810 | DeBeer et al. | Sep 2010 | A1 |
| 20100228285 | Miles et al. | Sep 2010 | A1 |
| 20100234940 | Dolan | Sep 2010 | A1 |
| 20100249908 | Chau et al. | Sep 2010 | A1 |
| 20100249917 | Zhang | Sep 2010 | A1 |
| 20100256737 | Pollock et al. | Oct 2010 | A1 |
| 20100262232 | Annest | Oct 2010 | A1 |
| 20100280603 | Maisano et al. | Nov 2010 | A1 |
| 20100280606 | Naor | Nov 2010 | A1 |
| 20100312333 | Navia et al. | Dec 2010 | A1 |
| 20100324595 | Linder et al. | Dec 2010 | A1 |
| 20100331971 | Keranen | Dec 2010 | A1 |
| 20110004227 | Goldfarb et al. | Jan 2011 | A1 |
| 20110004296 | Lutter et al. | Jan 2011 | A1 |
| 20110004299 | Navia et al. | Jan 2011 | A1 |
| 20110015729 | Carpentier et al. | Jan 2011 | A1 |
| 20110021985 | Spargias | Jan 2011 | A1 |
| 20110022165 | Oba et al. | Jan 2011 | A1 |
| 20110029072 | Gabbay | Feb 2011 | A1 |
| 20110040374 | Goetz et al. | Feb 2011 | A1 |
| 20110040375 | Letac et al. | Feb 2011 | A1 |
| 20110046662 | Moszner et al. | Feb 2011 | A1 |
| 20110054466 | Rothstein et al. | Mar 2011 | A1 |
| 20110054596 | Taylor | Mar 2011 | A1 |
| 20110054598 | Johnson | Mar 2011 | A1 |
| 20110066233 | Thornton et al. | Mar 2011 | A1 |
| 20110071626 | Wright et al. | Mar 2011 | A1 |
| 20110077730 | Fenster | Mar 2011 | A1 |
| 20110082538 | Dahlgren et al. | Apr 2011 | A1 |
| 20110087322 | Letac et al. | Apr 2011 | A1 |
| 20110093063 | Schreck | Apr 2011 | A1 |
| 20110098525 | Kermode et al. | Apr 2011 | A1 |
| 20110106247 | Miller et al. | May 2011 | A1 |
| 20110112625 | Ben-Muvhar et al. | May 2011 | A1 |
| 20110112632 | Chau et al. | May 2011 | A1 |
| 20110118830 | Liddicoat et al. | May 2011 | A1 |
| 20110125257 | Seguin et al. | May 2011 | A1 |
| 20110125258 | Centola | May 2011 | A1 |
| 20110137326 | Bachman | Jun 2011 | A1 |
| 20110137397 | Chau | Jun 2011 | A1 |
| 20110137409 | Yang et al. | Jun 2011 | A1 |
| 20110137410 | Hacohen | Jun 2011 | A1 |
| 20110144742 | Madrid et al. | Jun 2011 | A1 |
| 20110166636 | Rowe | Jul 2011 | A1 |
| 20110172784 | Richter et al. | Jul 2011 | A1 |
| 20110178597 | Navia et al. | Jul 2011 | A9 |
| 20110184510 | Maisano et al. | Jul 2011 | A1 |
| 20110190877 | Lane et al. | Aug 2011 | A1 |
| 20110190879 | Bobo et al. | Aug 2011 | A1 |
| 20110202076 | Richter | Aug 2011 | A1 |
| 20110208283 | Rust | Aug 2011 | A1 |
| 20110208293 | Tabor | Aug 2011 | A1 |
| 20110208298 | Tuval et al. | Aug 2011 | A1 |
| 20110213459 | Garrison et al. | Sep 2011 | A1 |
| 20110213461 | Seguin et al. | Sep 2011 | A1 |
| 20110218619 | Benichou et al. | Sep 2011 | A1 |
| 20110218620 | Meiri et al. | Sep 2011 | A1 |
| 20110224785 | Hacohen | Sep 2011 | A1 |
| 20110238159 | Guyenot et al. | Sep 2011 | A1 |
| 20110245911 | Quill et al. | Oct 2011 | A1 |
| 20110245917 | Savage et al. | Oct 2011 | A1 |
| 20110251675 | Dwork | Oct 2011 | A1 |
| 20110251676 | Sweeney et al. | Oct 2011 | A1 |
| 20110251678 | Eidenschink et al. | Oct 2011 | A1 |
| 20110251679 | Wiemeyer et al. | Oct 2011 | A1 |
| 20110251680 | Tran et al. | Oct 2011 | A1 |
| 20110251682 | Murray, III et al. | Oct 2011 | A1 |
| 20110251683 | Tabor | Oct 2011 | A1 |
| 20110257721 | Tabor | Oct 2011 | A1 |
| 20110257729 | Spenser et al. | Oct 2011 | A1 |
| 20110257736 | Marquez et al. | Oct 2011 | A1 |
| 20110257737 | Fogarty et al. | Oct 2011 | A1 |
| 20110264191 | Rothstein | Oct 2011 | A1 |
| 20110264196 | Savage et al. | Oct 2011 | A1 |
| 20110264198 | Murray, III et al. | Oct 2011 | A1 |
| 20110264199 | Tran et al. | Oct 2011 | A1 |
| 20110264200 | Tran et al. | Oct 2011 | A1 |
| 20110264201 | Yeung et al. | Oct 2011 | A1 |
| 20110264202 | Murray, III et al. | Oct 2011 | A1 |
| 20110264203 | Dwork et al. | Oct 2011 | A1 |
| 20110264206 | Tabor | Oct 2011 | A1 |
| 20110264208 | Duffy et al. | Oct 2011 | A1 |
| 20110270276 | Rothstein et al. | Nov 2011 | A1 |
| 20110271967 | Mortier et al. | Nov 2011 | A1 |
| 20110282438 | Drews et al. | Nov 2011 | A1 |
| 20110282439 | Thill et al. | Nov 2011 | A1 |
| 20110282440 | Cao et al. | Nov 2011 | A1 |
| 20110283514 | Fogarty et al. | Nov 2011 | A1 |
| 20110288632 | White | Nov 2011 | A1 |
| 20110288634 | Tuval et al. | Nov 2011 | A1 |
| 20110295354 | Bueche et al. | Dec 2011 | A1 |
| 20110295363 | Girard et al. | Dec 2011 | A1 |
| 20110301688 | Dolan | Dec 2011 | A1 |
| 20110301701 | Padala et al. | Dec 2011 | A1 |
| 20110301702 | Rust et al. | Dec 2011 | A1 |
| 20110306916 | Nitzan et al. | Dec 2011 | A1 |
| 20110307049 | Kao | Dec 2011 | A1 |
| 20110313452 | Carley et al. | Dec 2011 | A1 |
| 20110313515 | Quadri et al. | Dec 2011 | A1 |
| 20110319989 | Lane et al. | Dec 2011 | A1 |
| 20110319991 | Hariton et al. | Dec 2011 | A1 |
| 20120010694 | Lutter et al. | Jan 2012 | A1 |
| 20120016468 | Robin et al. | Jan 2012 | A1 |
| 20120022629 | Perera et al. | Jan 2012 | A1 |
| 20120022633 | Olson et al. | Jan 2012 | A1 |
| 20120022637 | Ben-Muvhar | Jan 2012 | A1 |
| 20120022639 | Hacohen et al. | Jan 2012 | A1 |
| 20120022640 | Gross et al. | Jan 2012 | A1 |
| 20120035703 | Lutter et al. | Feb 2012 | A1 |
| 20120035713 | Lutter et al. | Feb 2012 | A1 |
| 20120035722 | Tuval | Feb 2012 | A1 |
| 20120041547 | Duffy et al. | Feb 2012 | A1 |
| 20120041551 | Spenser et al. | Feb 2012 | A1 |
| 20120046738 | Lau et al. | Feb 2012 | A1 |
| 20120046742 | Tuval et al. | Feb 2012 | A1 |
| 20120053676 | Ku et al. | Mar 2012 | A1 |
| 20120053682 | Kovalsky et al. | Mar 2012 | A1 |
| 20120053688 | Fogarty et al. | Mar 2012 | A1 |
| 20120059454 | Millwee et al. | Mar 2012 | A1 |
| 20120059458 | Buchbinder et al. | Mar 2012 | A1 |
| 20120065464 | Ellis et al. | Mar 2012 | A1 |
| 20120078237 | Wang et al. | Mar 2012 | A1 |
| 20120078353 | Quadri et al. | Mar 2012 | A1 |
| 20120078357 | Conklin | Mar 2012 | A1 |
| 20120083832 | Delaloye et al. | Apr 2012 | A1 |
| 20120083839 | Letac et al. | Apr 2012 | A1 |
| 20120083879 | Eberhardt et al. | Apr 2012 | A1 |
| 20120089223 | Nguyen et al. | Apr 2012 | A1 |
| 20120101570 | Tuval et al. | Apr 2012 | A1 |
| 20120101571 | Thambar et al. | Apr 2012 | A1 |
| 20120101572 | Kovalsky et al. | Apr 2012 | A1 |
| 20120123511 | Brown | May 2012 | A1 |
| 20120123530 | Carpentier et al. | May 2012 | A1 |
| 20120130473 | Norris et al. | May 2012 | A1 |
| 20120130474 | Buckley | May 2012 | A1 |
| 20120130475 | Shaw | May 2012 | A1 |
| 20120136434 | Carpentier et al. | May 2012 | A1 |
| 20120150218 | Sandgren et al. | Jun 2012 | A1 |
| 20120165915 | Melsheimer et al. | Jun 2012 | A1 |
| 20120165930 | Gifford, III et al. | Jun 2012 | A1 |
| 20120179244 | Schankereli et al. | Jul 2012 | A1 |
| 20120197292 | Chin-Chen et al. | Aug 2012 | A1 |
| 20120283824 | Lutter et al. | Nov 2012 | A1 |
| 20120290062 | McNamara et al. | Nov 2012 | A1 |
| 20120296360 | Norris et al. | Nov 2012 | A1 |
| 20120296418 | Bonyuet et al. | Nov 2012 | A1 |
| 20120300063 | Majkrzak et al. | Nov 2012 | A1 |
| 20120310328 | Olson et al. | Dec 2012 | A1 |
| 20120323316 | Chau et al. | Dec 2012 | A1 |
| 20120330408 | Hillukkia et al. | Dec 2012 | A1 |
| 20130006347 | McHugo | Jan 2013 | A1 |
| 20130018450 | Hunt | Jan 2013 | A1 |
| 20130018458 | Yohanan et al. | Jan 2013 | A1 |
| 20130030519 | Tran et al. | Jan 2013 | A1 |
| 20130035759 | Gross et al. | Feb 2013 | A1 |
| 20130041451 | Patterson et al. | Feb 2013 | A1 |
| 20130046373 | Cartledge et al. | Feb 2013 | A1 |
| 20130066341 | Ketai et al. | Mar 2013 | A1 |
| 20130066342 | Dell et al. | Mar 2013 | A1 |
| 20130079872 | Gallagher | Mar 2013 | A1 |
| 20130116780 | Miller et al. | May 2013 | A1 |
| 20130123896 | Bloss et al. | May 2013 | A1 |
| 20130123900 | Eblacas et al. | May 2013 | A1 |
| 20130150945 | Crawford et al. | Jun 2013 | A1 |
| 20130150956 | Yohanan et al. | Jun 2013 | A1 |
| 20130158647 | Norris et al. | Jun 2013 | A1 |
| 20130166017 | Cartledge et al. | Jun 2013 | A1 |
| 20130166022 | Conklin | Jun 2013 | A1 |
| 20130172978 | Vidlund et al. | Jul 2013 | A1 |
| 20130172992 | Gross et al. | Jul 2013 | A1 |
| 20130178930 | Straubinger et al. | Jul 2013 | A1 |
| 20130190861 | Chau et al. | Jul 2013 | A1 |
| 20130211501 | Buckley et al. | Aug 2013 | A1 |
| 20130245742 | Norris | Sep 2013 | A1 |
| 20130253643 | Rolando et al. | Sep 2013 | A1 |
| 20130261737 | Costello | Oct 2013 | A1 |
| 20130261738 | Clague et al. | Oct 2013 | A1 |
| 20130274870 | Lombardi et al. | Oct 2013 | A1 |
| 20130282059 | Ketai et al. | Oct 2013 | A1 |
| 20130289711 | Liddy et al. | Oct 2013 | A1 |
| 20130289740 | Liddy et al. | Oct 2013 | A1 |
| 20130297013 | Klima et al. | Nov 2013 | A1 |
| 20130304197 | Buchbinder et al. | Nov 2013 | A1 |
| 20130304200 | McLean et al. | Nov 2013 | A1 |
| 20130310928 | Morriss et al. | Nov 2013 | A1 |
| 20130325114 | McLean et al. | Dec 2013 | A1 |
| 20130331929 | Mitra et al. | Dec 2013 | A1 |
| 20140000112 | Braido et al. | Jan 2014 | A1 |
| 20140005778 | Buchbinder et al. | Jan 2014 | A1 |
| 20140018911 | Zhou et al. | Jan 2014 | A1 |
| 20140018915 | Biadillah et al. | Jan 2014 | A1 |
| 20140031928 | Murphy et al. | Jan 2014 | A1 |
| 20140046430 | Shaw | Feb 2014 | A1 |
| 20140052237 | Lane et al. | Feb 2014 | A1 |
| 20140067050 | Costello et al. | Mar 2014 | A1 |
| 20140067054 | Chau et al. | Mar 2014 | A1 |
| 20140081376 | Burkart et al. | Mar 2014 | A1 |
| 20140106951 | Brandon | Apr 2014 | A1 |
| 20140120287 | Jacoby et al. | May 2014 | A1 |
| 20140121749 | Roeder | May 2014 | A1 |
| 20140121763 | Duffy et al. | May 2014 | A1 |
| 20140135894 | Norris et al. | May 2014 | A1 |
| 20140135895 | Andress et al. | May 2014 | A1 |
| 20140142681 | Norris | May 2014 | A1 |
| 20140142688 | Duffy et al. | May 2014 | A1 |
| 20140148891 | Johnson | May 2014 | A1 |
| 20140163690 | White | Jun 2014 | A1 |
| 20140172069 | Roeder et al. | Jun 2014 | A1 |
| 20140172077 | Bruchman et al. | Jun 2014 | A1 |
| 20140172082 | Bruchman et al. | Jun 2014 | A1 |
| 20140188210 | Beard et al. | Jul 2014 | A1 |
| 20140188221 | Chung et al. | Jul 2014 | A1 |
| 20140194981 | Menk et al. | Jul 2014 | A1 |
| 20140194983 | Kovalsky et al. | Jul 2014 | A1 |
| 20140207231 | Hacohen et al. | Jul 2014 | A1 |
| 20140214157 | Bortlein et al. | Jul 2014 | A1 |
| 20140214159 | Vidlund et al. | Jul 2014 | A1 |
| 20140222136 | Geist et al. | Aug 2014 | A1 |
| 20140222142 | Kovalsky et al. | Aug 2014 | A1 |
| 20140236287 | Clague et al. | Aug 2014 | A1 |
| 20140236289 | Alkhatib | Aug 2014 | A1 |
| 20140249622 | Carmi et al. | Sep 2014 | A1 |
| 20140257461 | Robinson et al. | Sep 2014 | A1 |
| 20140257467 | Lane et al. | Sep 2014 | A1 |
| 20140257475 | Gross et al. | Sep 2014 | A1 |
| 20140257476 | Montorfano et al. | Sep 2014 | A1 |
| 20140277358 | Slazas | Sep 2014 | A1 |
| 20140277409 | Bortlein et al. | Sep 2014 | A1 |
| 20140277411 | Börtlein et al. | Sep 2014 | A1 |
| 20140277418 | Miller | Sep 2014 | A1 |
| 20140277422 | Ratz et al. | Sep 2014 | A1 |
| 20140277427 | Ratz et al. | Sep 2014 | A1 |
| 20140296962 | Cartledge et al. | Oct 2014 | A1 |
| 20140296969 | Tegels et al. | Oct 2014 | A1 |
| 20140324164 | Gross et al. | Oct 2014 | A1 |
| 20140331475 | Duffy et al. | Nov 2014 | A1 |
| 20140336744 | Tani et al. | Nov 2014 | A1 |
| 20140343670 | Bakis et al. | Nov 2014 | A1 |
| 20140358222 | Gorman, III et al. | Dec 2014 | A1 |
| 20140358224 | Tegels et al. | Dec 2014 | A1 |
| 20140379065 | Johnson et al. | Dec 2014 | A1 |
| 20140379074 | Spence et al. | Dec 2014 | A1 |
| 20140379076 | Vidlund et al. | Dec 2014 | A1 |
| 20150018944 | O'Connell et al. | Jan 2015 | A1 |
| 20150032205 | Matheny | Jan 2015 | A1 |
| 20150045881 | Lim | Feb 2015 | A1 |
| 20150094802 | Buchbinder et al. | Apr 2015 | A1 |
| 20150119970 | Nakayama et al. | Apr 2015 | A1 |
| 20150127097 | Neumann et al. | May 2015 | A1 |
| 20150142100 | Morriss et al. | May 2015 | A1 |
| 20150142103 | Vidlund | May 2015 | A1 |
| 20150157458 | Tharnbar et al. | Jun 2015 | A1 |
| 20150164640 | McLean et al. | Jun 2015 | A1 |
| 20150173896 | Richter et al. | Jun 2015 | A1 |
| 20150173897 | Raanani et al. | Jun 2015 | A1 |
| 20150196390 | Ma et al. | Jul 2015 | A1 |
| 20150196393 | Vidlund et al. | Jul 2015 | A1 |
| 20150216661 | Hacohen et al. | Aug 2015 | A1 |
| 20150238313 | Spence et al. | Aug 2015 | A1 |
| 20150245934 | Lombardi et al. | Sep 2015 | A1 |
| 20150250588 | Yang et al. | Sep 2015 | A1 |
| 20150272730 | Melnick et al. | Oct 2015 | A1 |
| 20150272734 | Sheps et al. | Oct 2015 | A1 |
| 20150282964 | Beard et al. | Oct 2015 | A1 |
| 20150320556 | Levi et al. | Nov 2015 | A1 |
| 20150327994 | Morriss et al. | Nov 2015 | A1 |
| 20150328000 | Ratz et al. | Nov 2015 | A1 |
| 20150335429 | Morriss et al. | Nov 2015 | A1 |
| 20150351903 | Morriss et al. | Dec 2015 | A1 |
| 20150351904 | Cooper et al. | Dec 2015 | A1 |
| 20150359629 | Ganesan et al. | Dec 2015 | A1 |
| 20160008129 | Siegel | Jan 2016 | A1 |
| 20160030169 | Shahriari | Feb 2016 | A1 |
| 20160030171 | Quijano et al. | Feb 2016 | A1 |
| 20160089482 | Siegenthaler | Mar 2016 | A1 |
| 20160095700 | Righini | Apr 2016 | A1 |
| 20160100939 | Armstrong et al. | Apr 2016 | A1 |
| 20160106539 | Buchbinder et al. | Apr 2016 | A1 |
| 20160113766 | Ganesan et al. | Apr 2016 | A1 |
| 20160113768 | Ganesan et al. | Apr 2016 | A1 |
| 20160125160 | Heneghan et al. | May 2016 | A1 |
| 20160175095 | Dienno et al. | Jun 2016 | A1 |
| 20160220367 | Barrett | Aug 2016 | A1 |
| 20160228247 | Maimon et al. | Aug 2016 | A1 |
| 20160242902 | Morriss et al. | Aug 2016 | A1 |
| 20160270911 | Ganesan et al. | Sep 2016 | A1 |
| 20160310268 | Oba et al. | Oct 2016 | A1 |
| 20160310274 | Gross et al. | Oct 2016 | A1 |
| 20160317301 | Quadri et al. | Nov 2016 | A1 |
| 20160317305 | Pelled et al. | Nov 2016 | A1 |
| 20160324633 | Gross et al. | Nov 2016 | A1 |
| 20160324635 | Vidlund et al. | Nov 2016 | A1 |
| 20160324640 | Gifford, III et al. | Nov 2016 | A1 |
| 20160331526 | Schweich, Jr. et al. | Nov 2016 | A1 |
| 20160331527 | Vidlund et al. | Nov 2016 | A1 |
| 20160338706 | Rowe | Nov 2016 | A1 |
| 20160367360 | Cartledge et al. | Dec 2016 | A1 |
| 20160367368 | Vidlund et al. | Dec 2016 | A1 |
| 20160374801 | Jimenez et al. | Dec 2016 | A1 |
| 20160374802 | Levi et al. | Dec 2016 | A1 |
| 20170042678 | Ganesan et al. | Feb 2017 | A1 |
| 20170049435 | Sauer et al. | Feb 2017 | A1 |
| 20170056166 | Ratz et al. | Mar 2017 | A1 |
| 20170056171 | Cooper et al. | Mar 2017 | A1 |
| 20170065411 | Grundeman et al. | Mar 2017 | A1 |
| 20170100236 | Robertson et al. | Apr 2017 | A1 |
| 20170128205 | Tamir et al. | May 2017 | A1 |
| 20170135816 | Lashinski et al. | May 2017 | A1 |
| 20170189174 | Braido et al. | Jul 2017 | A1 |
| 20170196688 | Christianson et al. | Jul 2017 | A1 |
| 20170196692 | Kirk et al. | Jul 2017 | A1 |
| 20170209264 | Chau et al. | Jul 2017 | A1 |
| 20170216026 | Quill et al. | Aug 2017 | A1 |
| 20170224323 | Rowe et al. | Aug 2017 | A1 |
| 20170231757 | Gassler | Aug 2017 | A1 |
| 20170231759 | Geist et al. | Aug 2017 | A1 |
| 20170231760 | Lane et al. | Aug 2017 | A1 |
| 20170239048 | Goldfarb et al. | Aug 2017 | A1 |
| 20170333183 | Backus | Nov 2017 | A1 |
| 20170333187 | Hariton et al. | Nov 2017 | A1 |
| 20180000580 | Wallace et al. | Jan 2018 | A1 |
| 20180014930 | Hariton et al. | Jan 2018 | A1 |
| 20180021129 | Peterson et al. | Jan 2018 | A1 |
| 20180028215 | Cohen | Feb 2018 | A1 |
| 20180049873 | Manash et al. | Feb 2018 | A1 |
| 20180055628 | Patel et al. | Mar 2018 | A1 |
| 20180055630 | Patel et al. | Mar 2018 | A1 |
| 20180098850 | Rafiee et al. | Apr 2018 | A1 |
| 20180116790 | Ratz et al. | May 2018 | A1 |
| 20180116843 | Schreck et al. | May 2018 | A1 |
| 20180125644 | Conklin | May 2018 | A1 |
| 20180132999 | Perouse | May 2018 | A1 |
| 20180153689 | Maimon et al. | Jun 2018 | A1 |
| 20180161159 | Lee et al. | Jun 2018 | A1 |
| 20180177594 | Patel et al. | Jun 2018 | A1 |
| 20180206983 | Noe et al. | Jul 2018 | A1 |
| 20180214263 | Rolando et al. | Aug 2018 | A1 |
| 20180243086 | Barbarino et al. | Aug 2018 | A1 |
| 20180250126 | O'connor et al. | Sep 2018 | A1 |
| 20180250147 | Syed | Sep 2018 | A1 |
| 20180296333 | Dixon et al. | Oct 2018 | A1 |
| 20180296336 | Cooper et al. | Oct 2018 | A1 |
| 20180296341 | Noe et al. | Oct 2018 | A1 |
| 20180344457 | Gross et al. | Dec 2018 | A1 |
| 20180353294 | Calomeni et al. | Dec 2018 | A1 |
| 20180360457 | Ellis et al. | Dec 2018 | A1 |
| 20190000613 | Delgado et al. | Jan 2019 | A1 |
| 20190015200 | Delgado et al. | Jan 2019 | A1 |
| 20190021852 | Delgado et al. | Jan 2019 | A1 |
| 20190053896 | Adamek-bowers et al. | Feb 2019 | A1 |
| 20190060060 | Chau et al. | Feb 2019 | A1 |
| 20190060068 | Cope et al. | Feb 2019 | A1 |
| 20190060070 | Groothuis et al. | Feb 2019 | A1 |
| 20190069997 | Ratz et al. | Mar 2019 | A1 |
| 20190083261 | Perszyk et al. | Mar 2019 | A1 |
| 20190105153 | Barash et al. | Apr 2019 | A1 |
| 20190117391 | Humair | Apr 2019 | A1 |
| 20190167423 | Hariton et al. | Jun 2019 | A1 |
| 20190175339 | Vidlund | Jun 2019 | A1 |
| 20190183639 | Moore | Jun 2019 | A1 |
| 20190192295 | Spence et al. | Jun 2019 | A1 |
| 20190216602 | Lozonschi | Jul 2019 | A1 |
| 20190336280 | Naor | Nov 2019 | A1 |
| 20190350701 | Adamek-bowers et al. | Nov 2019 | A1 |
| 20190365530 | Hoang et al. | Dec 2019 | A1 |
| 20190388218 | Vidlund et al. | Dec 2019 | A1 |
| 20190388220 | Vidlund et al. | Dec 2019 | A1 |
| 20200000449 | Goldfarb et al. | Jan 2020 | A1 |
| 20200000579 | Manash et al. | Jan 2020 | A1 |
| 20200015964 | Noe et al. | Jan 2020 | A1 |
| 20200030098 | Delgado et al. | Jan 2020 | A1 |
| 20200054335 | Hemandez et al. | Feb 2020 | A1 |
| 20200060818 | Geist et al. | Feb 2020 | A1 |
| 20200113677 | McCann et al. | Apr 2020 | A1 |
| 20200113689 | McCann et al. | Apr 2020 | A1 |
| 20200113692 | McCann et al. | Apr 2020 | A1 |
| 20200138567 | Marr et al. | May 2020 | A1 |
| 20200163761 | Hariton et al. | May 2020 | A1 |
| 20200214832 | Metchik et al. | Jul 2020 | A1 |
| 20200237512 | McCann et al. | Jul 2020 | A1 |
| 20200246136 | Marr et al. | Aug 2020 | A1 |
| 20200246140 | Hariton et al. | Aug 2020 | A1 |
| 20200253600 | Darabian | Aug 2020 | A1 |
| 20200261094 | Goldfarb et al. | Aug 2020 | A1 |
| 20200315786 | Metchik et al. | Oct 2020 | A1 |
| 20200337842 | Metchik et al. | Oct 2020 | A1 |
| 20210093449 | Hariton et al. | Apr 2021 | A1 |
| 20210113331 | Quadri et al. | Apr 2021 | A1 |
| 20210137680 | Kizuka et al. | May 2021 | A1 |
| 20210259835 | Tyler, II et al. | Aug 2021 | A1 |
| Number | Date | Country |
|---|---|---|
| 2822801 | Aug 2006 | CA |
| 103974674 | Aug 2014 | CN |
| 1264582 | Nov 2002 | EP |
| 1637092 | Mar 2006 | EP |
| 1768630 | Jan 2015 | EP |
| 2349124 | Oct 2018 | EP |
| 3583922 | Dec 2019 | EP |
| 3270825 | Apr 2020 | EP |
| 2485795 | Sep 2020 | EP |
| S53152790 | Dec 1978 | JP |
| 2001-0046894 | Jun 2001 | KR |
| 9843557 | Oct 1998 | WO |
| 9930647 | Jun 1999 | WO |
| 0047139 | Aug 2000 | WO |
| 0162189 | Aug 2001 | WO |
| 0182832 | Nov 2001 | WO |
| 0187190 | Nov 2001 | WO |
| 2003020179 | Mar 2003 | WO |
| 0328558 | Apr 2003 | WO |
| 2004028399 | Apr 2004 | WO |
| 2005107650 | Nov 2005 | WO |
| 2006007389 | Jan 2006 | WO |
| 2006007401 | Jan 2006 | WO |
| 2006054930 | Jul 2006 | WO |
| 2006070372 | Jul 2006 | WO |
| 2006086434 | Aug 2006 | WO |
| 2006089236 | Aug 2006 | WO |
| 2006116558 | Nov 2006 | WO |
| 2006128193 | Nov 2006 | WO |
| 2007047488 | Apr 2007 | WO |
| 207059252 | May 2007 | WO |
| 2008013915 | Jan 2008 | WO |
| 2008029296 | Mar 2008 | WO |
| 2008070797 | Jun 2008 | WO |
| 2008103722 | Aug 2008 | WO |
| 2009033469 | Mar 2009 | WO |
| 2009053497 | Apr 2009 | WO |
| 2009091509 | Jul 2009 | WO |
| 2010006627 | Jan 2010 | WO |
| 2010027485 | Mar 2010 | WO |
| 2010037141 | Apr 2010 | WO |
| 2010045297 | Apr 2010 | WO |
| 2010057262 | May 2010 | WO |
| 2010073246 | Jul 2010 | WO |
| 2010081033 | Jul 2010 | WO |
| 2010121076 | Oct 2010 | WO |
| 2011025972 | Mar 2011 | WO |
| 2011069048 | Jun 2011 | WO |
| 2011106137 | Sep 2011 | WO |
| 2011111047 | Sep 2011 | WO |
| 2011137531 | Nov 2011 | WO |
| 2011143263 | Nov 2011 | WO |
| 2011144351 | Nov 2011 | WO |
| 2011154942 | Dec 2011 | WO |
| 2012011108 | Jan 2012 | WO |
| 2012024428 | Feb 2012 | WO |
| 2012036740 | Mar 2012 | WO |
| 2012048035 | Apr 2012 | WO |
| 2012127309 | Sep 2012 | WO |
| 2012177942 | Dec 2012 | WO |
| 2013021374 | Feb 2013 | WO |
| 2013021375 | Feb 2013 | WO |
| 2013021384 | Feb 2013 | WO |
| 2013059747 | Apr 2013 | WO |
| 2013072496 | May 2013 | WO |
| 2013078497 | Jun 2013 | WO |
| 2013128436 | Jun 2013 | WO |
| 2013114214 | Aug 2013 | WO |
| 2013175468 | Nov 2013 | WO |
| 2014022124 | Feb 2014 | WO |
| 2014076696 | May 2014 | WO |
| 2014115149 | Jul 2014 | WO |
| 2014144937 | Sep 2014 | WO |
| 2014145338 | Sep 2014 | WO |
| 2014164364 | Oct 2014 | WO |
| 2014194178 | Dec 2014 | WO |
| 2015173794 | Nov 2015 | WO |
| 2016016899 | Feb 2016 | WO |
| 2016093877 | Jun 2016 | WO |
| 2016125160 | Aug 2016 | WO |
| 2017223486 | Dec 2017 | WO |
| 2018025260 | Feb 2018 | WO |
| 2018025263 | Feb 2018 | WO |
| 2018039631 | Feb 2018 | WO |
| 2018039631 | Mar 2018 | WO |
| 2018106837 | Jun 2018 | WO |
| 2018112429 | Jun 2018 | WO |
| 2018118717 | Jun 2018 | WO |
| 2018131042 | Jul 2018 | WO |
| 2018131043 | Jul 2018 | WO |
| 2019026059 | Feb 2019 | WO |
| 2019027507 | Feb 2019 | WO |
| 2019030753 | Feb 2019 | WO |
| 2019077595 | Apr 2019 | WO |
| 2019116369 | Jun 2019 | WO |
| 2019138400 | Jul 2019 | WO |
| 2019195860 | Oct 2019 | WO |
| 2019202579 | Oct 2019 | WO |
| 2020058972 | Mar 2020 | WO |
| 2020167677 | Aug 2020 | WO |
| Entry |
|---|
| ISR and WO mailed Feb. 6, 2013; PCT/IL2012/00292. |
| ISR and WO mailed Feb. 6, 2013; PCT/IL2012/000293. |
| ISR and WO mailed Sep. 4, 2014 PCT/IL2014/050087. |
| ISR and WO mailed Oct. 27, 2015; PCT/IL2015/050792. |
| ISR and WO mailed May 30, 2016; PCT/IL2016/050125. |
| Alexander Geha, et al; “Replacement of Degenerated Mitral and Aortic Bioprostheses Without Explantation”, Ann. Thorac. Surg. Jun. 2001, 72: 1509-1514. |
| Dominique Himbert MD; Mitral Regurgitation and Stenosis from Bioprosthesis and Annuloplasty Failure: Transcatheter Approaches and Outcomes:, 24 pages, Oct. 28, 2013. |
| Saturn Project; “A Novel Solution for Transcatheter Heart Valve Replacement Specifically Designed to Address Clinical Therapeutic Needs on Mitral Valve”, Dec. 2016; 8 pages. |
| Frank Langer MD et al; “Ring plus String; Papillary Muscle Repositioning as an Adjunctive Repair Technique for Ischemic Mitral Regurgitation”, J. Thoracic Cardiovasc. Surg. 133: 247-9, Jan. 2007. |
| Frank Langer MD et al; “Ring+String Successful Repair Technique for ischemic Mitral Regurgitation With Severe Leaflet Tethering”, Circulation 120[suppl 1]; S85-S91, Sep. 2009. |
| Francesco Maisano MD; Valvetech Cardiovalve: Novel Design Feature and Clinical Update, 2015; TCR Presentation re Cardiovalve; 10 pages. |
| Giovanni Righini; Righini presentation EuroPCR May 2015 (Saturn)-(downloaded from: https://www.pcronline.com/Cases-resourcesimages/Resources/Course-videos-slides/2015/Cardiovascularinnovation-pipeline-Mitral-and-tricuspid-valve-interventions). |
| John G. Webb, et al; “Transcatheter Valve-in-Valve Implantation for Failed Bioprosthetic Heart Valves”, Circulation 2010; 1121; 1848-1847, originally published online Apr. 12, 2010. |
| S. Willeke, et al; Detachable shape-memory sewing ring for heart valves:, Artificial Organs, 16: 294-297; 1992 (an abstract). |
| U.S. Appl. No. 61/283,819. |
| U.S. Appl. No. 61/492,449 |
| U.S. Appl. No. 61/515,372. |
| U.S. Appl. No. 61/525,281. |
| U.S. Appl. No. 61/537,276. |
| U.S. Appl. No. 61/555,160. |
| U.S. Appl. No. 61/588,892. |
| USPTO NFOA dated Oct. 23, 2017 in connection with U.S. Appl. No. 14/763,004. |
| USPTO FOA dated Jan. 17, 2018 in connection with U.S. Appl. No. 14/763,004. |
| USPTO NFOA dated Feb. 27, 2018 in connection with U.S. Appl. No. 15/197,069. |
| USPTO NFOA dated Dec. 7, 2017 in connection with U.S. Appl. No. 15/213,791. |
| USPTO Interview Summary dated Feb. 8, 2018 in connection with U.S. Appl. No. 15/213,791. |
| USPTO NFOA dated Jan. 5, 2018 in connection with U.S. Appl. No. 15/541,783. |
| USPTO NFOA dated Feb. 2, 2018 in connection with U.S. Appl. No. 15/329,920. |
| Invitation to pay additional fees dated Jan. 2, 2018; PCT/IL2017/050849. |
| IPRP issued Feb. 5, 2019; PCT/IL2017/050849. |
| IPRP issued Feb. 12, 2019; PCT/IL2017/050873. |
| ISR and WO mailed Dec. 5, 2018; PCT/IL2018/050725. |
| ISR and WO mailed Nov. 9, 2018; PCT/IL2018/050869. |
| ISR and WO mailed Jan. 25, 2019; PCT/IL2018/051122. |
| ISR and WO mailed May 13, 2019: PCT/IL2018/051350. |
| ISR and WO mailed Apr. 25, 2019; PCT/IL2019/050142. |
| EPO OA dated Mar. 25, 2019; Appln. No. 14710060.6. |
| USPTO FOA dated Mar. 4, 2019 in connection with U.S. Appl. No. 14/763,004. |
| USPTO FOA dated Jan. 30, 2019 in connection with U.S. Appl. No. 15/872,501. |
| USPTO FOA dated Feb. 5, 2019 in connection with U.S. Appl. No. 15/899,858. |
| USPTO NFOA dated Oct. 25, 2018 in connection with U.S. Appl. No. 14/763,004. |
| USPTO NFOA dated Jan. 9, 2019 in connection with U.S. Appl. No. 15/329,920. |
| USPTO NFOA dated May 23, 2019 in connection with U.S. Appl. No. 15/668,659. |
| EESR dated Sep. 26, 2018; Appln. No. 1816784.7. |
| First Chinese Office Action dated Nov. 5, 2018; Appln. No. 201680008328.5. |
| Invite to pay additional fees dated Oct. 11, 2018; PCTI/IL2018/050725. |
| USPTO NFOA dated Dec. 4, 2018 in connection with U.S. Appl. No. 16/045,059. |
| USPTO NOA mailed Sep. 25, 2018 in connection with U.S. Appl. No. 15/188,507. |
| USPTO FOA dated Feb. 10, 2014 in connection with U.S. Appl. No. 13/033,852. |
| USPTO FOA dated Feb. 15, 2013 in connection with U.S. Appl. No. 12/840,463. |
| USPTO FOA dated Feb. 25, 2016 in connection with U.S. Appl. No. 14/522,987. |
| USPTO FOA dated Mar. 25, 2015 in connection with U.S. Appl. No. 12/840,463. |
| USPTO FOA dated Apr. 13, 2016 in connection with U.S. Appl. No. 14/626,267. |
| USPTO FOA dated May 23, 2014 in connection with U.S. Appl. No. 13/412,814. |
| USPTO FOA dated Jul. 18, 2013 in connection with U.S. Appl. No. 13/044,694. |
| USPTO FOA dated Jul. 23, 2013 in connection with U.S. Appl. No. 12/961,721. |
| USPTO FOA dated Sep. 12, 2013 in connection with U.S. Appl. No. 13/412,814. |
| USPTO NFOA dated Jan. 18, 2017 in connection with U.S. Appl. No. 14/626,267. |
| USPTO NFOA dated Jan. 21, 2016 in connection with U.S. Appl. No. 14/237,264. |
| USPTO NFOA dated Feb. 6, 2013 in connection with U.S. Appl. No. 13/412,814. |
| USPTO NFOA dated Feb. 7, 2017 in connection with U.S. Appl. No. 14/689,608. |
| An International Preliminary Report on Patentability dated Oct. 20, 2020, which issued during the prosecution of Applicants PCT/IL2019/050142. |
| An Office Action dated Oct. 5, 2020, which issued during the prosecution of Canadian Patent Application No. 2,973,940. |
| Notice of Allowance dated Nov. 19, 2020, which issued during the prosecution of U.S. Appl. No. 16/318,025. |
| An Office Action dated Sep. 24, 2020, which issued during the prosecution of U.S. Appl. No. 16/811,732. |
| An Office Action summarized English translation and Search Report dated Nov. 25, 2020, which issued during the prosecution of Chinese Patent Application No. 201910449820.1. |
| An Office Action dated Nov. 30, 2020, which issued during the prosecution of U.S. Appl. No. 16/138,129. |
| USPTO NFOA dated Jun. 4, 2014 in connection with U.S. Appl. No. 12/840,463. |
| USPTO NFOA dated Jun. 17, 2014 in connection with U.S. Appl. No. 12/961,721. |
| USPTO NFOA dated Jun. 30, 2015 in connection with U.S. Appl. No. 14/522,987. |
| USPTO NFOA dated Jul. 2, 2014 in connection with U.S. Appl. No. 13/811,308. |
| USPTO NFOA dated Jul. 3, 2014 in connection with U.S. Appl. No. 13/033,852. |
| USPTO NFOA dated Aug. 2, 2013 in connection with U.S. Appl. No. 13/033,852. |
| USPTO NFOA dated Sep. 19, 2014 in connection with U.S. Appl. No. 13/044,694. |
| USPTO NFOA dated Nov. 8, 2013 in connection with U.S. Appl. No. 12/840,463. |
| USPTO NFOA dated Nov. 23, 2012 in connection with U.S. Appl. No. 13/033,852. |
| USPTO NFOA dated Nov. 27, 2015 in connection with U.S. Appl. No. 14/626,267. |
| USPTO NFOA dated Nov. 28, 2012 in connection with U.S. Appl. No. 12/961,721. |
| USPTO NFOA dated Dec. 10, 2015 in connection with U.S. Appl. No. 14/237,258. |
| USPTO NFOA dated Dec. 31, 2012 in connection with U.S. Appl. No. 13/044,694. |
| USPTO NFOA dated May 29, 2012 in connection with U.S. Appl. No. 12/840,463. |
| USPTO NOA dated May 20, 2016 in connection with U.S. Appl. No. 14/237,258. |
| USPTO NOA dated Jul. 6, 2017 in connection with U.S. Appl. No. 14/689,608. |
| USPTO NOA dated Aug. 18, 2017 in connection with U.S. Appl. No. 14/689,608. |
| USPTO NOA mailed Feb. 11, 2015 in connection with U.S. Appl. No. 13/033,852. |
| USPTO NOA mailed Mar. 10, 2015 in connection with U.S. Appl. No. 13/811,308. |
| USPTO NOA mailed Apr. 8, 2016 in connection with U.S. Appl. No. 14/237,258. |
| USPTO NOA mailed May 5, 2015 in connection with U.S. Appl. No. 12/840,463. |
| USPTO NOA dated May 10, 2016 in connection with U.S. Appl. No. 14/237,258. |
| USPTO NOA mailed May 22, 2017 in connection with U.S. Appl. No. 14/689,608. |
| USPTO NOA mailed Aug. 15, 2014 in connection with U.S. Appl. No. 13/412,814. |
| USPTO RR dated Jan. 20, 2016 in connection with U.S. Appl. No. 14/161/921. |
| USPTO RR dated Feb. 3, 2014 in connection with U.S. Appl. No. 13/811,308. |
| USPTO RR dated Apr. 21, 2017 in connection with U.S. Appl. No. 15/213,791. |
| USPTO RR dated Jul. 2, 2012 in connection with U.S. Appl. No. 13/033,852. |
| USPTO RR dated Aug. 13, 2012 in connection with U.S. Appl. No. 13/044,694. |
| USPTO RR dated Aug. 14, 2012 in connection with U.S. Appl. No. 12/961,721. |
| USPTO RR dated Aug. 28, 2015 in connection with U.S. Appl. No. 14/237,264. |
| USPTO RR dated Sep. 26, 2016 in connection with U.S. Appl. No. 14/763,004. |
| Invitation to pay Additional Fees dated Jun. 12, 2014; PCT/IL2014/050087. |
| Invitation to pay Additional Fees dated Sep. 29, 2017; PCT/IL2017/050873. |
| EESR dated Jun. 29, 2017; Appln. No. 11809374.9. |
| EESR dated Feb. 18, 2015; Appln. No. 12821522.5. |
| EPO Office Action dated Feb. 10, 2017; Appln. No. 12821522.5. |
| UK Office Action dated Feb. 7, 2017; Appln. GB1613219.3. |
| IPRP issued Dec. 2, 2013; PCT/IL2011/000582. |
| IPRP issued Sep. 11, 2012; PCT/IL2011/000231. |
| IPRP issued Feb. 11, 2014; PCT/IL2012/000292. |
| IPRP issued Feb. 11, 2014 PCT/IL2012/000293. |
| ISR and WO mailed Dec. 5, 2011; PCT/IL11/00582. |
| ISR and WO mailed Mar. 17, 2014; PCT/IL13/50937. |
| ISR and WO mailed Oct. 13, 2011; PCT/IL11/00231. |
| An Office Action dated Jun. 25, 2019, which issued during the prosecution of U.S. Appl. No. 15/329,920. |
| An Office Action dated May 16, 2019, which issued during the prosecution of U.S. Appl. No. 15/433,547. |
| An Office Action dated Aug. 1, 2019, which issued during the prosecution of U.S. Appl. No. 15/668,559. |
| An Office Action dated Aug. 16, 2019, which issued during the prosecution of U.S. Appl. No. 15/668,659. |
| An Office Action dated Jun. 19, 2019, which issued during the prosecution of U.S. Appl. No. 15/682,789. |
| An Office Action dated Jun. 14, 2019, which issued during the prosecution of U.S. Appl. No. 15/703,385. |
| An Office Action dated Oct. 4, 2019, which issued during the prosecution of U.S. Appl. No. 16/183,140. |
| An Office Action dated Jun. 13, 2019, which issued during the prosecution of U.S. Appl. No. 16/388,038. |
| An Office Action dated Sep. 13, 2019, which issued during the prosecution of U.S. Appl. No. 16/460,313. |
| An Office Action dated Nov. 26, 2019, which issued during the prosecution of U.S. Appl. No. 16/532,945. |
| An Office Action dated Nov. 1, 2019, which issued during the prosecution of U.S. Appl. No. 15/872,501. |
| U.S. Appl. No. 14/689,608, filed Apr. 17, 2015, published as 2015/0216661, issued as U.S. Pat. No. 9,763,657. |
| U.S. Appl. No. 15/691,032, filed Aug. 30, 2017, published as 2017/0360426, issued as U.S. Pat. No. 10,512,456. |
| U.S. Appl. No. 61/492,449, filed Jun. 2, 2011. |
| U.S. Appl. No. 12/840,463, filed Jul. 21, 2010, published as 2012/0022639, issued as U.S. Pat. No. 9,132,009. |
| U.S. Appl. No. 13/033,852, filed Feb. 24, 2011, published as 2012/0022640, issued as U.S. Pat. No. 8,992,604. |
| U.S. Appl. No. 13/811,308, filed Mar. 7, 2013, published as 2013/0172992, issued as U.S. Pat. No. 9,017,399. |
| Notice of Allowance dated May 7, 2020, which issued during the prosecution of U.S. Appl. No. 16/637,166. |
| Sündermann, Simon H., et al. “Feasibility of the Engager™ aortic transcatheter valve system using a flexible over-the-wire design.” European Journal of Cardio-Thoracic Surgery 42.4 (2012): e48-e52. |
| An Office Action summarized English translation and Search Report dated Jul. 3, 2020, which issued during the prosecution of Chinese Patent Application No. 201780061210.3. |
| Serruys, P. W., Piazza, N., Cribier, A., Webb, J., Laborde, J. C., & de Jaegere, P. (Eds.). (2009). Transcatheter aortic valve implantation: tips and tricks to avoid failure. CRC Press.—Screenshots from Google Books downloaded from: https://books.google.co.il/books?id=FLzLBQAAQBAJ&Ipg=PA198&ots=soqWrDH-y_&dq=%20%22Edwards%20SAPIEN%22&Ir&pg=PA20#v=onepage&q=%22Edwards%20SAPIEN%22&f=false ; Downloaded on Jun. 18, 2020. |
| An International Search Report and a Written Opinion both dated Jun. 24, 2020, which issued during the prosecution of Applicant's PCT/IL2019/051398. |
| An Office Action dated Jul. 14, 2020, which issued during the prosecution of U.S. Appl. No. 16/324,339. |
| Notice of Allowance dated Aug. 28, 2020, which issued during the prosecution of U.S. Appl. No. 16/324,339. |
| Notice of Allowance dated Jul. 29, 2020, which issued during the prosecution of U.S. Appl. No. 16/132,937. |
| An Office Action dated Jul. 29, 2020, which issued during the prosecution of U.S. Appl. No. 16/269,328. |
| Notice of Allowance dated Aug. 26, 2020, which issued during the prosecution of U.S. Appl. No. 16/269,328. |
| An Office Action dated Aug. 7, 2020, which issued during the prosecution of U.S. Appl. No. 15/668,659. |
| Tchetche, D. and Nicolas M. Van Mieghem: “New-generation TAVI devices: description and specifications” EuroIntervention, 2014, No. 10:U90-U100. |
| Symetis S.A.: “Acurate neo™ Aortic Bioprosthesis for Implantation using the ACURATE neo™ TA Transapical Delivery System in Patients with Severe Aortic Stenosis,” Clinical Investigation Plan, Protocol No. 2015-01, Vs. No. 2, 2015:1-76. |
| Notice of Allowance dated Sep. 10, 2020, which issued during the prosecution of U.S. Appl. No. 15/600,190. |
| An Office Action dated Jan. 6, 2020, which issued during the prosecution of U.S. Appl. No. 16/660,231. |
| An Office Action dated Dec. 31, 2019, which issued during the prosecution of U.S. Appl. No. 16/183,140. |
| An Office Action dated Jan. 14, 2020, which issued during the prosecution of U.S. Appl. No. 16/284,331. |
| Notice of Allowance dated Jan. 13, 2020, which issued during the prosecution of U.S. Appl. No. 15/956,956. |
| European Search European Search Report dated Mar. 5, 2020 which issued during the prosecution of Applicant's European App No. 17752184.6. |
| European Search Report dated Mar. 4, 2020 which issued during the prosecution of Applicant's European App No. 16706913.7. |
| Notice of Allowance dated Mar. 12, 2020, which issued during the prosecution of U.S. Appl. No. 16/460,313. |
| An Office Action dated Jan. 9, 2020, which issued during the prosecution of U.S. Appl. No. 15/600,190. |
| An Office Action dated Jan. 3, 2020, which issued during the prosecution of U.S. Appl. No. 16/678,355. |
| An Office Action dated Feb. 6, 2020, which issued during the prosecution of U.S. Appl. No. 15/668,659. |
| Poirier, Nancy C., et al. “A novel repair for patients with atrioventricular septal defect requiring reoperation for left atrioventricular valve regurgitation.” European journal of cardio-thoracic surgery 18.1 (2000): 54-61. |
| An Office Action dated Mar. 29, 2021, which issued during the prosecution of U.S. Appl. No. 16/738,516. |
| Ando, Tomo, et al. “Iatrogenic ventricular septal defect following transcatheter aortic valve replacement: a systematic review.” Heart, Lung and Circulation 25.10 (2016): 968-974. |
| Urena, Marina, et al. “Transseptal transcatheter mitral valve replacement using balloon-expandable transcatheter heart valves: a step-by-step approach.” JACC: Cardiovascular Interventions 10.19 (2017): 1905-1919. |
| An English summary of an Official Action dated Mar. 29, 2021, which issued during the prosecution of Chinese Patent Application No. 201780061210.3. |
| An International Search Report and a Written Opinion both dated Jan. 28, 2020, which issued during the prosecution of Applicant's PCT/IL2019/051031. |
| An International Preliminary Report on Patentability dated Mar. 9, 2021, which issued during the prosecution of Applicant's PCT/IL2019/051031. |
| An Office Action dated May 4, 2021, which issued during the prosecution of U.S. Appl. No. 16/636,204. |
| Notice of Allowance dated May 17, 2021, which issued during the prosecution of U.S. Appl. No. 16/138,129. |
| Notice of Allowance dated Jun. 4, 2021, which issued during the prosecution of U.S. Appl. No. 16/802,353. |
| An Office Action dated May 12, 2021, which issued during the prosecution of Canadian Patent Application No. 2,973,940. |
| Petition for Inter Partes Review of U.S. Pat. No. 10,702,385—dated Jun. 4, 2021. |
| Declaration of Ivan Vesely, Ph.D. In Support of Petition for Inter Partes Review of U.S. Pat. No. 10,702,385—dated Jun. 4, 2021. |
| European Search Report dated Jun. 10, 2021 which issued during the prosecution of Applicant's European App No. 21157988.3. |
| An Invitation to pay additional fees dated May 19, 2021, which issued during the prosecution of Applicant's PCT/IL2021/050132. |
| An International Search Report and a Written Opinion both dated Jul. 12, 2021, which issued during the prosecution of Applicant's PCT/IL2021/050132. |
| IPR2021-00383 Petitioners' Authorized Reply to Patent Owner's Preliminary Response dated May 27, 2021. |
| Exhibit 1014—Transcript of proceedings held May 20, 2021 (Edwards Lifesciences vs. Cardiovalve). |
| Exhibit 1015—Facilitate, Meriam-Webster.com, https://www.merriamwebster.com/dictionary/facilitate (visited May 26, 2021). |
| Patent Owner's Authorized Surreply to Petitioner's Reply to Patent Owner's Preliminary Response dated Jun. 4, 2021 (Edwards Lifesciences vs. Cardiovalve). |
| An Office Action dated Aug. 18, 2021, which issued during the prosecution of U.S. Appl. No. 17/210,183. |
| Institution decision dated Jul. 20, 2021(Edwards Lifesciences vs. Cardiovalve). |
| An Office Action dated Dec. 24, 2020, which issued during the prosecution of U.S. Appl. No. 16/144,054. |
| An Office Action dated Feb. 2, 2021, which issued during the prosecution of U.S. Appl. No. 16/811,732. |
| An Office Action dated Jan. 13, 2021, which issued during the prosecution of European Patent Application No. 15751089.2. |
| Maisano, F., et al. “The edge-to-edge technique: a simplified method to correct mitral insufficiency.” European journal of cardio-thoracic surgery 13.3 (1998): 240-246. |
| Declaration of Dr. Ivan Vesely, Ph.D. in Support of Petition for Inter Partes Review of U.S. Pat. No. 10,226,341—dated Dec. 17, 2020. |
| Petition for Inter Partes Review of U.S. Pat. No. 10,226,341 and Exhibits 1001-1013—dated Dec. 29, 2020. |
| An Office Action together with an English summary dated Mar. 3, 2021, which issued during the prosecution of Chinese Patent Application No. 201780047391.4. |
| Fucci, C., et al. “Improved results with mitral valve repair using new surgical techniques.” European journal of cardio-thoracic surgery 9.11 (1995): 621-627. |
| Declaration of Ivan Vesely, Ph.D., in Support of Petition for Inter PartesReview of U.S. Pat. No. 7,563,267—dated May 29, 2019. |
| U.S. Appl. No. 60/128,690, filed Apr. 9, 1999. |
| Batista, Randas JV, et al. “Partial left ventriculectomy to treat end-stage heart disease.” The Annals of thoracic surgery 64.3 (1997): 634-638. |
| Beall Jr, Arthur C., et al. “Clinical experience with a dacron velour-covered teflon-disc mitral-valve prosthesis.” The Annals of thoracic surgery 5.5 (1968): 402-410. |
| Kalbacher, D., et al. “1000 MitraClip™ procedures: Lessons learnt from the largest single-centre experience worldwide.” (2019): 3137-3139. |
| U.S. Appl. No. 60/613,867, filed Sep. 27, 2004. |
| Mitral Valve Academic Research Consortium. “Clinical Trial Design Principles and Endpoint Definitions for Transcatheter Mitral Valve Repair and Replacement: Part 1: Clinical Trial Design Principles a Consensus Document from the Mitral Valve Academic Research Consortium.” Journal of the American College of Cardiology 66.3 (2015): 278-307. |
| Office Action dated Apr. 11, 2022 in U.S. Appl. No. 17/473,472. |
| Office Action dated Jan. 26, 2022 in U.S. Appl. No. 16/888,210. |
| Notice of Allowance dated Jan. 31, 2022 in U.S. Appl. No. 17/479,418. |
| Preliminary Guidance Patent Owner's Motion to Amend dated Jan. 31, 2022 in IPR2021-00383. |
| Office Action dated Mar. 18, 2022 in U.S. Appl. No. 16/746,489. |
| Notice of Allowance dated Mar. 4, 2022 in U.S. Appl. No. 16/768,909. |
| Notice of Allowance dated Mar. 22, 2022 in U.S. Appl. No. 17/366,711. |
| Office Action dated Jan. 24, 2022 in U.S. Appl. No. 16/135,466. |
| Office Action dated Dec. 9, 2021 in U.S. Appl. No. 16/135,969. |
| An Office Action dated Nov. 25, 2021, which issued during the prosecution of European Patent Application No. 18826823.9. |
| IPR2021-01051 Institution decision dated Dec. 10, 2021. |
| Notice of Allowance dated Dec. 7, 2021, which issued during the prosecution of U.S. Appl. No. 17/394,807. |
| Notice of Allowance dated Dec. 6, 2021, which issued during the prosecution U.S. Appl. No. 16/738,516. |
| Notice of Allowance dated Dec. 29, 2021, which issued during the prosecution of U.S. Appl. No. 17/210,183. |
| IPR2021-00383 Petitioners' Reply to Patent Owner's Response dated Jan. 5, 2022. |
| IPR2021-00383 Petitioners' Opposition to Patent Owner's Contingent Motion to Amend dated Jan. 5, 2022. |
| An Office Action dated Sep. 22, 2021, which issued during the prosecution of European Patent Application No. 20714289.4. |
| Summary of Examination Notice dated Jan. 6, 2022, which issued during the prosecution of Chinese Patent Application No. 201880064313.X. |
| An Office Action dated Jan. 12, 2022, which issued during the prosecution of U.S. Appl. No. 17/101,787. |
| An Office Action dated Sep. 9, 2021, which issued during the prosecution of U.S. Appl. No. 16/768,909. |
| An Office Action dated Sep. 15, 2021, which issued during the prosecution of U.S. Appl. No. 16/135,599. |
| IPR2021-00383 Deposition of Dr. Ivan Vesely, dated Sep. 22, 2021. |
| An Office Action dated Oct. 21, 2021, which issued during the prosecution of U.S. Appl. No. 17/335,845. |
| European Search Report dated Oct. 11, 2021 which issued during the prosecution of Applicant's European App No. 21176010.3. |
| Fann, James I., et al. “Beating heart catheter-based edge-to-edge mitral valve procedure in a porcine model: efficacy and healing response.” Circulation 110.8 (2004): 988-993. |
| Feldman, Ted, et al. “Percutaneous mitral repair with the MitraClip system: safety and midterm durability in the initial Everest (Endovascular Valve Edge-to-Edge REpair Study) cohort.” Journal of the American College of Cardiology 54.8 (2009): 686-694. |
| IPR2021-00383 Patent Owner's Contingent Motion to Amend Under 37 C.F.R. §42.121 dated Oct. 13, 2021. |
| IPR2021-00383 Patent Owner's Response Pursuant to 37 C.F.R. § 42.120 dated Oct. 13, 2021. |
| IPR2021-00383 Second Declaration of Dr. Michael Sacks dated Oct. 13, 2021. |
| An Office Action dated Oct. 21, 2021, which issued during the prosecution of U.S. Appl. No. 17/306,231. |
| Maisano, Francesco, et al. “The evolution from surgery to percutaneous mitral valve interventions: the role of the edge-to-edge technique.” Journal of the American College of Cardiology 58.21 (2011): 2174-2182. |
| Cardiovalve Exhibit 2009—Percutaneous Mitral Leaflet Repair: MitraClip® Therapy for Mitral Regurgitation (2012). |
| Feldman, Ted, et al. “Percutaneous mitral valve repair using the edge-to-edge technique: six-month results of the Everest Phase I Clinical Trial.” Journal of the American College of Cardiology 46.11 (2005): 2134-2140. |
| An Office Action summarized English translation and Search Report dated Oct. 8, 2021, which issued during the prosecution of Chinese Patent Application No. 201780061210.3. |
| An Office Action dated Nov. 4, 2021, which issued during the prosecution of U.S. Appl. No. 17/366,711. |
| An Office Action summarized English translation and Search Report dated Aug. 12, 2021, which issued during the prosecution of Chinese Patent Application No. 201880058940.2. |
| Number | Date | Country | |
|---|---|---|---|
| 20200078002 A1 | Mar 2020 | US |
| Number | Date | Country | |
|---|---|---|---|
| 61492449 | Jun 2011 | US |
| Number | Date | Country | |
|---|---|---|---|
| Parent | 15691032 | Aug 2017 | US |
| Child | 16680739 | US | |
| Parent | 14689608 | Apr 2015 | US |
| Child | 15691032 | US | |
| Parent | 13811308 | US | |
| Child | 14689608 | US |
| Number | Date | Country | |
|---|---|---|---|
| Parent | 13033852 | Feb 2011 | US |
| Child | 13811308 | US | |
| Parent | 12840463 | Jul 2010 | US |
| Child | 13033852 | US | |
| Parent | 12840463 | Jul 2010 | US |
| Child | PCT/IL2011/000582 | US |
